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Abstract
This thesis is written as part of Marie-Curie international training network called
Mid-TECH. Mid-TECH is devoted to improve mid-infrared (MIR) technologies and
consists of 15 PhD projects across European universities. This thesis aims to evaluate
new technologies and concepts developed by the project partners for their applicability
in a biomedical setting. The clinical problem to diagnose oesophageal cancers serves
as an example case for this. The thesis consists of three projects all aimed to further
the understanding of MIR hyperspectral imaging.
The first project discussed in chapter 5 demonstrates the use of an new design of
the United States Airforce resolution test chart. The new test chart is developed to
evaluate spatial resolution of MIR hyperspectral imaging systems. The use of different
materials is discussed and the new iteration of the thes chart is evaluated using a
state of the art MIR imaging system.
The second project discussed in chapter 6 evaluates the technical differences and
their practical implications of discrete frequency MIR imaging systems compared
to continuum source systems. A comparison of the two system types is drawn for
imaging paraffin embedded sections of oesophageal tissue. Furthermore the effect of
chemically removing the paraffin from the sample is compared to a mathematical
correction algorithm. The system performance is compared based on their ability to
differentiate healthy from cancerous tissue.
The third project discussed in chapter 7 evaluates the potential of a new MIR detection
scheme called upconversion in combination with a novel MIR laser source. It is a
prove of concept study demonstrating that those two technologies can be deployed to
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This thesis is written in 7 independent chapters which the author envisions to be
readable independently apart from the summary and discussion chapter.
This work involved a range of external collaborations with other university groups
working with imaging systems or setups of varying degrees of maturity, from proof
of concept to industrial research grade. Therefore, each chapter is structured like
a scientific paper. The chapters 2, 3 and 4 are written in review style providing
theoretical backbone of the thesis. Chapter 5, 6 and 7 are original research chapters
with independent methods and discussion of the results. The final chapter 8 puts the
individual experiments into a wider context.
1.2 Aims of the Thesis
The principal aim of this thesis is to evaluate novel mid-infrared (MIR) systems for
their use for histopathological work flows. Research investigating mechanisms for
generation and detection of MIR radiation is going through a renaissance to the date
this thesis is written. Therefore, it is likely that technological improvements in these
areas will progress to applications. MIR hyperspectral imaging as discussed in great
detail here is believed to have great potential to improve clinical decision making.
In this thesis, the author gives an overview how new MIR imaging technology could
be harnessed to improve workflows in a clinical environment. For this purpose the
thesis looks at the diagnosis of oesophageal adenocarcinoma as an example case.
1
2 Mid-Infrared Technology
Disclaimer: This chapter is an adaptation from a review paper entitled: ‘Mid-IR
hyperspectral imaging for label-free histopathology and cytology‘ published by the author
of the thesis and collaborators in the IOP journal of optics [1]. The review is published
licensed under Creative Commons Attribution 3.0 licence which allows reuse and remix
of content. The following chapter is remixed from sections: 2. Mid-infrared light
sources; 3. Mid-infrared detection systems and 4. Mid-infrared micro spectroscopy. In
addition to the review a section discussing OPOs has been added as they are important
for this work.
2.1 Introduction
The last decade has seen the early exploration of myriad applications of vibrational
spectroscopy for clinical applications. Both mid-infrared (MIR) absorption spec-
troscopy and Raman spectroscopy, utilising the inelastic scattering of laser light, probe
the specific vibrational energy levels of molecules in the target volume. The two
techniques are complementary, probing different vibrational modes based on specific
vibrational selection rules. The various methodologies are undergoing translational de-
velopment for a range of applications from in vivo surface [2] and deep tissue probes [3]
providing real-time analysis of disease specific tissue molecular compositional changes;
to point of care testing of ex vivo tissues or body fluids [4, 5]; to microspectroscopic
analysis and imaging of tissue and cells [6–8]. Until recently the limited speed of
vibrational spectroscopic imaging has prevented its translation as a tool in digital
spectral histopathology. However, new developments in MIR technologies and a greater
understanding of the key discriminating features is leading to a resurgence of interest
in MIR spectral histopathology as a tool for rapid molecular identification of disease,
particularly to support pathologists in making difficult decisions when assessing early
malignant disease [9, 10].
MIR technology is experiencing a renaissance with development of new light sources
and detection systems. This is driven by the need for faster imaging systems, as MIR
2
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hyperspectral imaging has proven to be a valuable tool for medical diagnostics but is
hampered by relatively slow throughput. Imaging speed has significantly increased
within the last five years and is on the brink of becoming competitive to gold standard
histopathology procedures. Potentially it could furthermore, offer more detailed
chemical information without the need for staining or labelling.
Imaging biological samples using resonant absorption in the MIR region is a particularly
challenging task compared to imaging in the visible range of the electromagnetic
spectrum. Here we define the MIR region in terms of wavelengths ranging between 2
and 12 µm (5000 to 800 cm−1). A major challenge when measuring the IR absorption
spectrum of biological matter is the interference of water absorption, i.e. OH stretching
modes giving rise to a broad band centred at 3300 cm−1and bending mode at 1620 cm−1.
Furthermore, many materials have absorption bands in the MIR range and so there
are only a few transparent materials that can be used as substrates, for instance. A
problem of equal importance is, that the optical imaging elements made from these
materials are less widely available than standard silica or quartz optics.
The scope of this chapter is to give an overview of the state of the art of MIR tech-
nologies. The reader is also referred to recent reviews in this area: Bhargava et al. [11]
and Gardner et al. [12] both covering complementary aspects of the field.
Traditional visible light microscopy often requires specific histological staining to
reveal morphological patterns in biomedical samples. This requires separate sections
for each marker of interest, whereas vibrational spectroscopic imaging can potentially
provide information on various markers at once, from a single section of unstained
tissue.
Raman microspectroscopy, although able to provide high resolution chemical mapping
of cells and tissues, is either significantly slower than MIR imaging, or when used in
fast non-linear modalities [13] has less chemical information. The non-linear modalities
such as coherent anti-stokes Raman scattering (CARS) or stimulated Raman scattering
(SRS) are mostly limited to probing only the higher wavenumber region of a vibrational
spectrum while being more complex in optical setup compared to a discrete frequency
MIR imaging system. Notable however is their ability to perform better in aqueous
media than MIR systems which makes them superior for studying living organisms
but less favourable for studying clinical samples.
Mass spectrometry based imaging techniques [14, 15] offer a comparably good chemical
contrast to MIR and Raman imaging but are significantly slower, more expensive in
CHAPTER 2. MID-INFRARED TECHNOLOGY 3
2.1. Introduction
operation, and notably destructive. In comparison to other techniques, MIR imaging
offers high sensitivity, reasonable spatial resolution (of the order of 1-10 µm), non-
destructive testing and specific chemical contrast without the requirement of extensive
sample preparation.
In simplistic terms, the four key components of a MIR imaging system are the
light source, the imaging optics e.g. microscope, the wavelength separating unit or
spectrometer, and the detector.
All novel developments in each of these areas are be discussed and the implications
for MIR hyperspectral imaging of histological tissue sections considered. The focus
lies on farfield techniques, likely to be applied to large scale tissues and cells at scales
of 10‘s µm to mm. There are many rapid developments in nearfield IR techniques,
beyond the scope of this introduction, such as scanning near-field optical microscopy
(SNOM) or nano-IR, the reader is pointed to a review by Bazylewski et al. [16] for a
general overview or others for more specific nano-IR applications [17–23].
Integration of the new IR technologies into an imaging system, often using coherent
light sources, can require careful consideration of the impact of the optical systems on
the imaging quality achieved, particularly when trying to achieve diffraction limited
spatial resolution. Designing an imaging system is a complex task and needs to consider
all requirements and components to maximise performance. The most important
parameters in a spectral measurement are the spectral range (defined by the light
source, optical components, and detector), spectral resolution (either defined by a
spectrometer, wavelength tuning element or inherently from the linewidth of the
monochromatic excitation light), spatial resolution (defined by the objective‘s numeric
apeture) and speed (given by brightness of the light source, speed of wavelength
selection and sensitivity of the camera). Here it is discussed, how each new instrumental
approach is likely to affect those parameters.
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2.2 MIR Light Sources
The light source is a key component of MIR imaging systems and its choice has a
major influence on the rest of the system design. To date, only two types of radiation
source can be seen as well-established sources for MIR spectroscopy and imaging:
globar and synchrotron illumination. In recent years, additional technologies have
become available in the MIR region. These include: quantum cascade lasers (QCL),
MIR supercontinuum light sources, optical parametric oscillators (OPO) and free
electron lasers (FELs).
A globar is the simplest and cheapest broadband light source. It consists of a filament
made of silicon carbide which is heated up to 1000 to 1650 ◦C by an electric current
and radiates according to Planck‘s law (i.e. as a black-body). The output radiation is
spatially and temporally incoherent, and has very low intensity noise, being limited
by the drive current and the stability of the cooling system. It has a large spectral
emission range (2-25 µm) but low spectral intensity (radiant intensity per wavelength)
stemming from the principle of black-body radiation.
Synchrotron radiation and free electron lasers (FEL) are easily able to cover the whole
MIR spectral range with significantly higher brightness than globars. Their working
principle is based on the Bremsstrahlung effect, whereby electrons are accelerated
to relativistic speeds while the transverse part of their momentum is modulated by
a magnetic field (e.g. by an undulator or bending magnet) leading to emission of
electromagnetic radiation in a cone, spanning a wide range of wavelengths. While the
undulator induced radiation is inherently incoherent with arbitrary phase relation,
some designs [24] can achieve coherence over certain spectral ranges in the far-IR. Free
electron lasers emit coherent radiation in both spatial and temporal domain [25, 26].
The FEL from Tokyo University of Science, for example, emits a selectable wavelength
in the range 5-16 µm [27]. It can operate at 5 Hz repetition frequency and macro-pulse
duration of approx 2µs, which actually consists of a set of 2 ps micro-pulses with 350
ps periodicity, delivering 6-8 mJ per macro-pulse. FELs as well as synchrotrons are
extremely large and expensive to maintain; therefore, they are available only for a few
experiments in the basic sciences. High costs and lack of portability of these systems
make them impractical for general use. Other notable MIR light sources [28] are solid
state lasers and fibre lasers but will not be discussed further here. They can offer
extremely high peak power and ultrashort (fs) pulses, but, at the expense of cost and
bulk.
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The most promising commercially available new technologies are MIR semiconductor
lasers and supercontinuum light sources, as they combine high brightness and small
size requirements.
2.2.1 Quantum Cascade Lasers (QCL)
Since the first demonstration of a working QCL in 1994 by Capasso et al. [29] with
peak power of 8 mW at 4.2 µm , the QCL concept has since been very successfully. By
now, the peak power has risen to over 200 W [30]. In continuous-wave (cw) operation
the average output power exceeds several watts [31, 32] as well. The emission spectral
range has improved, and lasing has been demonstrated on spectral bands spanning
from 2.63 µm [33–35] to 24.4 µm .
Similar to diode lasers (DL) and interband cascade lasers (ICL) [36], pumping of
the laser is realised by applying a voltage across the QCL chip. Carefully designed
periodic heterostructures as visualised in figure 2.1 enable electrons to move into an
upper laser level in the conduction band, where these electrons undergo a radiative
transition to a lower energy state, also within the conduction band [37]. Finally, the
electrons exit the lower laser state by non-radiative transition and are re-injected into
the upper laser state of the next cascade (period). After moving through all cascades,
typically 30-40 within one laser structure, the electrons are collected at the positive
contact. The electrons‘ wavefunctions are composed of spatially-modulated Bloch
states of the conduction band during the entire process, so no holes are involved,
which is not the case for DL and ICL.
Increasing the number of cascades can technically achieved total quantum efficiencies
greater than 100 % because each cascade can result in up to one photon per electron [38]
and the electron can be reused by the next cascade. The power efficiency is largely
independent on the number of cascades, but increases with the cascade number due
to better overlap of the optical mode with the gain. For high power, it appears
that having 10-15 cascades [39] is optimum because of a need to balance thermal
conductance with power efficiency. One can also enhance the emission range of
a single chip by heterogeneous stacking of cascades with gain centred at different
wavelengths [40–43].
To achieve individual energy levels, in an otherwise continuous band of energies,
quantum confinement has to be established. This is realised by surrounding a thin
(nm scale) layer of low bandgap material with a different lattice matched material of
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Figure 2.1: Simplified QCL energy schematic.
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higher conduction band offset. This creates a quantum hole with individual energy
levels along one spatial dimension. Additional energy levels need to be introduced into
the sequence for proper functioning of the laser (e.g. for efficient depopulation of the
lower laser state), resulting in a set of quantum holes and barriers. Such a set is called
a period or a cascade, and as is apparent from its name they can be stacked together
quite easily as the major carrier are electrons. By heterogeneous stacking of periods, a
gain spectrum at different wavelengths can be designed. Therefore, those strucktures
can be stacked periodically to form several pairs of quantum wells and barriers on
top of each other. This cascading structure enhances the quantum efficiency of the
process [38] and gives the lasers their name (QCL).
QCL chips emit a Fabry-Perot (FP) spectrum centred at a particular wavelength
(design dependent) that can be broader than 10 % of the central wavelength. One way
to achieve single longitudinal mode lasing is to etch a diffraction grating on top of the
laser stripe, which acts as a distributed Bragg reflector (DBR) and provides feedback
for a narrow band of wavelengths; such a laser is called distributed feedback laser
(DFB). Tuning is achieved by either directly changing the temperature of the chip or
by modifying its pumping current. This technique however only allows tuning of less
than 1 % of the central wavelength [44]. To overcome this limitation, several DFB
lasers with different grating periods can be manufactured on one chip. Lasing from
5.9 to 10.9 µm with over 50 mW peak power throughout a wide range of wavelengths
has been demonstrated [40].
A different approach is to use just one stripe, but use an asymmetric sampled grating
DFB with an additional amplifier section [45]. With this configuration, over 5 W
power in pulsed operation at 4.8 µm and tunability of 270 nm (300 nm) has been
achieved, as well as 1.25 W in cw operation. By combining these two approaches [43],
thereby creating a set of 8 stripes with different sampled grating DFB with additional
on-chip sections responsible for combining the beams, tuning from 6.2 to 9.1 µm has
been demonstrated [43]. All the above mentioned designs emphasise probably the
biggest benefits of semiconductor versus other laser types, i.e. small size, completely
electronic tuning and enormous mass production potential.
Single mode lasing and tuning can also be achieved by mounting an FP laser into an
external cavity (EC) [46]. Applying an antireflection coating on at least one facet of
the QCL chip suppresses the FP modes and allows wavelength selection by tuning
an optical element in the cavity. In Littrow and Littman-Metcalf configuration, a
diffraction grating is utilised for this purpose, achieving laser line widths of below
8 CHAPTER 2. MID-INFRARED TECHNOLOGY
2.2. MIR Light Sources
1 cm−1[47, 48]. An alternative to this is the use of interference filters and retroreflectors.
This has been successfully demonstrated [49] over a wavelength range of 4 - 4.3 µm and
shows comparable results to grating based designs. If broader emission wavelength
can be tolerated, acousto-optic modulators (AOM) and simple mirrors can also be
used for tuning, thus achieving switching time between wavelengths under 1 µs [50]
instead of several milliseconds, typical for micro-electro-mechanical systems (MEMS).
Dual wavelength operation and tuning is also possible with AOM tuning [51].
EC-QCLs with tuneability in pulsed mode from 7.6 to 11.4 µm , with peak power of
up to 1 W and average power of 15 mW have been realised [42]; higher powers have
been achieved in the narrowed band of 7 to 8.9 µm with a maximum power of 200
mW [41]. Even by placing the QCL chip in these complex external cavities, the size is
still reasonably small, of the order of a few tens of cm. However, the spectral range
coverage of most commercially available laser chips is not sufficient to cover the full
wavelength range of interest. To overcome this limitation, several individual EC-QCL
chips are combined into a system with a common output port.
2.2.2 Supercontinuum Sources
Supercontinuum sources are well known to be powerful tools for microscopy and
spectroscopy applications due to their high brightness and very broad spectrum.
Supercontinuum generation was first demonstrated in bulk borosilicate glass by Alfano
and Shapiro in 1970 [52]. In this process, narrow band optical pulses undergo significant
spectral broadening through the interplay of a variety of non-linear optical effects in
the propagation medium, yielding a spectrally continuous output. Optical fibres have
proven to be particularly suitable for this purpose, as the light is strongly confined
over long interaction lengths, which enhances the efficiency of non-linear effects. With
the advent of fibre technologies such as high power pump diodes and gain fibres as
well as the development of new optical fibre materials, geometries and dispersion
profiles, it is now possible to design and build broadband supercontinuum sources at
wavelengths from ultraviolet to the infrared [53, 54].
In recent years, a great deal of effort has been put into extending emission capabil-
ity into the MIR. This pursuit requires the use of novel fluoride based fibres with
transmission windows in the 2-5µm region and chalcogenide materials that allow
supercontinuum generation extending to 13.3 µm [55, 56]. In the 2-4.5 µm region,
power spectral density values of several hundred µW/nm have been reported [55].
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Beyond 5 µm , experimental demonstrations have shown power spectral density lev-
els of 1-2µW/nm [57]. Simulations of alternative conversion schemes indicate that
there is potential to achieve power densities of over 10 µW/nm at wavelengths as
long as 10 µm [58]. However, it is worth noting that current commercially available
MIR supercontinuum sources do not extend beyond a wavelength of 4.5 µm (around
2200 cm−1).
Fibre based supercontinuum sources have a high inherent beam quality, enabling
diffraction limited performance and high spatial coherence. Due to their large spectral
bandwidth, supercontinuum sources exhibit extremely low temporal coherence effec-
tively eliminating speckle in broadband illumination situations. However, applications
that require narrow filtering of the supercontinuum may exhibit speckle [59].
Furthermore, fibre based MIR supercontinuum sources can be made compact, ro-
bust, and affordable ($50K-$100K) thus making them very attractive for practical
applications. While only just appearing on the market, commercially available MIR su-
percontinuum sources are relatively inexpensive and can be purchased for comparable
prices to those of current commercial turn-key QCL systems in the same wavelength
range.
As supercontinuum sources are inherently broadband, their direct use for hyperspectral
imaging requires a spectrometer or wavelength selection element. Utilising acousto-
optic tuneable filters (AOTF), they can also be operated in a narrowband imaging
scheme which has been demonstrated for wavelengths up to 4.5 µm [59, 60]. Yet,
at any longer wavelengths, there are currently no commercially available AOTFs.
Thus, the use of longer wavelength supercontinuum source requires an interferometer,
monochromator or a novel upconversion scheme [61].
2.2.3 Optical Parametric Oscillators (OPO)
Optical parametric oscillators are a well-established technology for generating light
in the visible spectrum but are more difficult to build for MIR applications. They
are however particularly good at generating high intensity monochromatic radiation
for spectroscopic purposes [62]. OPOs utilise difference frequency generation (DFG)
between two laser beams referred to as pump and signal beams generating a third
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beam referred to as idler beam. The frequency δi of the idler beam is determined by
the law of energy conservation as difference of pump δp and signal δs frequencies:
hδi = hδp − hδs (2.1)
In order for the DFG to work efficiently all three beams need to conserve momentum
(∆k = 0) which is referred to as phase matched. The phase mismatch is expressed
as:










This principle allows to to build a DFG laser system with two input lasers. The system
generates the desired idler beam by depleting the input signal and pump beams. An
OPO system in contrast to that utilises the properties of quantum noise to generate
signal and idler photon both from only one pump beam. The nonline crystal is placed
in a cavity which is resonant to the signal wavelength. This principle however only
works with sufficiently high pump laser power as the parametric generation of the
signal needs to exceed the round trip loss of the cavity. Therfore, each OPO has a
threshold pump power which needs to be surpassed in order to generate the desired
idler photons.
Most OPOs utilize quasi phase matching created by special periodically poled non-
linear crystals [63]. The crystals can be grown with a fanned poling structure effectively
providing different refractive indices for different crystal positions. The generated
wavelength is dependent on the refractive index. This effect can be used to coarse tune
the output wavelength of the OPO by changing the refractive index, via temperature
tuning, or by translating the crystal along the fanning direction. Fine tuning can be
achieved by tuning the pump laser wavelength. The non-linear crystal is placed in a
cavity which enhances the generated output [64–66].
Most OPOs built this way operate in the 2-5 µm wavelength range utilising periodically
poled lithium niobate (PPLN) non-linear crystals. This configuration allows to build
OPO systems with output power ranging from 100 mW up to 10 W limited by the
damage threshold of the non-linear crystal [67].
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2.2.4 Comparison
In summary, globars are still the most universal low cost option available to cover the
entirety of the MIR spectral range of interest, but lacking brightness, especially for
high resolution imaging. Synchrotrons and FELs are bright tuneable light sources,
but very expensive and relatively inaccessible. Supercontinuum sources are close to
performing as well as synchrotrons, but do not cover the full MIR spectrum with
sufficient power. QCLs are becoming commercially mature (800 to 1800 cm−1) and
offer spatially and temporally coherent radiation in the longer wavelength MIR range,
but may require a multi-chip design to cover arbitrarily wide spectral ranges. As
QCLs are only available in the 6 to 12 µm wavelength range, OPOs are an alternative
to cover the shorter MIR wavelength until QCLs in that wavelength range become
available. For a further discussion of novel light sources in hyperspectral MIR imaging
the reader is pointed to chapter 8.
2.3 MIR Detection Systems
A primary limitation for widespread exploitation of the IR spectrum for imaging
applications is associated with a lack of sensitive, robust and easy to operate detection
systems. In comparison to visible detectors, IR detectors generally suffer from noise
originating from their own components emitting room temperature black-body radia-
tion; hence, low noise performance can only be achieved through cryogenic cooling.
Cold shields can be used to minimise the contribution from black-body radiation from
surrounding objects entering the detector. Generally, light detection is based either
on the absorption of photons by a sensor material resulting in a temperature increase
which can then be detected (thermal detectors) or in the creation of electron-hole
pairs giving rise to a current (photodetectors). Both these principles are routinely
used for IR detection and can be considered mature technologies optimised for decades.
Nevertheless, these detectors are still hampered by the need for cooling resulting in
high operational cost, complexity and size for low noise operation. Recently, new types
of detectors have emerged due to new technological achievements. These detectors
have different working principles and can overcome traditional shortcomings for special
applications.
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2.3.1 Thermal Detectors
A thermal detector is based on the temperature increase produced by absorbed incident
photons, which can be detected as a change in a temperature sensitive physical property
of the material. These detectors generally have slow temporal response, often in the
millisecond range, set by the thermal relaxation time of the sensor material. The
spectral response of thermal detectors depends on the absorption characteristics of
the material used. Thermal detectors are efficient for detection of high brightness
signals, and can be operated without cryogenic cooling. One of the major sources of
noise in thermal detectors relates to ambient thermal fluctuations transformed into a
variation in the conductance of the sensor material. In general, thermal detectors need
to have a low heat capacity for fast response time and good thermal isolation from the
surroundings [68, 69]. Applications of thermal detectors are generally limited by their
slow response time and lack of sensitivity, due to unwanted black-body radiation from
surroundings and temperature fluctuation in the detector material particularly in the
non-cooled versions. Thermal detectors are divided into different categories based on
the physical property responsible for generating the output signal in response to the
temperature variation. Two commonly used thermal detectors are presented below.
Bolometers The bolometer is a widely used thermal detector whereby the incident
radiation is absorbed in the sensor material, increasing the temperature of the material
relative to the surroundings. The sensor material has a temperature-dependent
electrical resistance, which can be read out as a voltage when passing a current
through the bolometer. The voltage can be expressed as:





α is the temperature coefficient of resistance of the sensor material that determines
the sensitivity of the bolometer. Preferred materials for bolometers should have low
heat capacity, low room temperature resistance and a large thermal coefficient of
resistance.
IR imaging in the long wavelength regime, e.g. 8 to 14 µm , can be achieved using
microbolometer arrays. These arrays consist typically of 320× 240 pixels, however
larger arrays with 640× 512 pixels are emerging. The individual pixel dimension is of
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the order of 20 µm × 20 µm ; however, as the pixel size decreases and thus the number
of pixels per unit area increases, a larger noise equivalent temperature difference
results due to smaller pixels being less sensitive to IR radiation [70].
Thermopiles The thermopile is another type of thermal detector, measuring temper-
ature via a series of thermocoupled devices. An infrared absorption film is deposited
on one side of the junction of a thermopile consisting of a series of thermocouple pairs.
Each pair has a junction of two conductors on either side of a thermal resistance
layer, resulting in a voltage in the range 10 to 100 mV proportional to the temperature
difference:
∆V = N(αa − αb)∆T (2.4)
αa and αb are the Seebeck coefficients, representing the magnitude of an induced
thermoelectric voltage in response to a temperature difference across that material, of
the two conductors forming the junction of the thermocouple pair. N is the number
of thermocouple pairs and ∆T is the temperature difference caused by the absorbed
IR radiation.
The sensitivity and the frequency response of thermopiles are inferior to bolometers,
nevertheless thermopiles are cost efficient and have found several applications in the
medical, farming and automotive industry [68, 69].
2.3.2 Photodetectors
The working principle of photodetectors is based on the photon absorption in a
semiconductor material resulting in an electronic transition generating a free charge
carrier. The bandgap of the semiconductor dictates the working wavelength range.
Silicon (Si) is the preferred material for detectors in the visible and near-infrared (NIR)
range, between 350 and 1100 nm. Moving towards longer wavelengths, indium gallium
arsenide (InGaAs) is the detector material of choice covering the range between 0.85
and 1.7 µm [71]. Indium antimonide (InSb) can be used in the range 3 to 5 µm whereas
mercury cadmium telluride (MCT) is commonly used in the wavelength ranges 3 to 5
and 8 to 12 µm [69, 72].
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Generally, Si and InGaAs detectors can have very high quantum efficiency reaching
more than 90 %, thus approaching single photon counting sensitivity, and have a rise
time in the order of 10-100 picoseconds. In contrast, InSb and MCT based detectors
typically have rise times in the order of 10-100 ns or more. The low bandgap energy of
the IR detector has a great impact on the noise performance, both in terms of internal
noise as well as sensitivity to black-body radiation originating from the detector
surroundings. In practical applications were high sensitivity is needed, the InSb and
MCT detectors are actively cooled in order to obtain low noise levels.
InGaAs and InSb Detectors Si and InGaAs detectors are divided into PIN diodes
and avalanche photodiodes (APD). In both cases the detector operates in the reverse-
biased region, which is known as photoconductive mode. The APDs work in the high
voltage reverse-biased region, where the signal-to-noise ratio can be improved by the
internal current gain due to the avalanche effect. APDs can be applied for single
photon detection when operating in the Geiger mode.
A great variety of InGaAs detectors has been developed for different applications;
Table 1 lists the properties of two typical APDs, working in the linear regime and
Geiger mode, respectively. Generally for all detectors, there is a trade-off between
high quantum efficiency, low noise and high bandwidth. InGaAs can also be applied
for NIR imaging.
Compared to silicon-based cameras used for visible light imaging, InGaAs cameras
suffer from higher dark current and larger readout noise as a result of the lower bandgap.
InSb photovoltaic detectors reach further into the MIR than InGaAs systems and
cover the wavelength range from 1 to 5.5 µm . They require to be cooled with liquid
nitrogen like mercury cadmium telluride (MCT) detectors. Their noise performance is
better than an MCT but as their spectral coverage is smaller they are rarely used for
biomedical imaging applications.
Mercury Cadmium Telluride (MCT) Detectors MCT is an alloy composed of
CdTe and HgTe. The absorption wavelength is determined by the amount of Cd in the
alloy. MCT detectors can cover a relatively large wavelength range (2-12 µm), which
makes them good candidates for Fourier transform infrared (FTIR) spectrometers.
MCT detectors have better performance than thermal detectors in terms of speed and
noise, although they are still inferior to InGaAs detectors. However, MCT detectors
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have been the detector of choice for MIR wavelengths, to which the InGaAs detectors
are insensitive. The bandgap of MCT is smaller than that of InGaAs allowing it to
detect longer wavelengths; however, this is also the main reason for the higher noise
level. In practical applications, MCT detectors are usually actively cooled in order to
reduce the noise.
2.3.3 Upconversion MIR detectors
Upconversion based detection is a fundamentally different approach for MIR sensing.
Using upconversion the low energy MIR radiation is not detected directly. It is
mixed with a high brightness laser in a transparent non-linear medium, shifting both
the spectral and spatial information from the low energy MIR range to the NIR or
visible range. This high frquency signal can be detected with sensitive and fast silicon
technology detectors.
Using a transparent medium for the non-linear process also has the effect, that no
black-body radiation from the medium is added to the MIR signal. Which is in strong
contrast to direct detection where the medium has to be highly absorbing. Secondly,
the non-linear process imposes a strong spectral and spatial filter to the upconversion
process, limiting the spectral bandwidth and field of view of the detector, hence
reducing the black-body noise picked up from the surroundings.
Upconversion is a parametric process and follows the principle of energy and momentum







, ~kIR + ~kpump = ~kup (2.5)
Figure 2.2: Non-collinear phase matching diagram
h is the Planck constant, c is the speed of light, λi and ki are the wavelength and the
wave vector for each specific photon. It should be emphasised that the phase matching
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condition acts in all spatial dimensions; therefore, the upconversion photon preserves
the spatial information of the IR photon, which enables upconversion imaging.
Upconversion technology has been deployed for both point detection [73] and for wide-
field imaging configurations [74–76]. Recently, a conversion efficiency of 20 % has been
demonstrated which presents the upconversion scheme as an emerging technique for
MIR detection [77]. Figure 2.3 shows an example of upconversion-based measurement
of MIR hyperspectral imaging.
Figure 2.3: A schematic of IR spectral imaging based on upconversion technology.
Here, a globar is used as broadband illumination source, whilst an upconversion
unit converts the transmitted radiation from the sample from MIR to NIR and a
silicon-based camera captures the images. The acquired broadband images are then
post processed to obtain a hyperspectral datacube made of a series of monochromatic
images.
Upconversion can be used over a substantial part of the IR spectral range depending
on the non-linear crystal used. Table 2.1 lists the properties of some commonly used
non-linear materials for the upconversion.





Lithium Niobate 1–4.5 14 4.6(LN)
Lithium Thioindate 1–8 7 6(LIS)
Silver Gallium Selenide 1–20 33 1(AGSe)
Silver Gallium Sulphide 2–11 11 1.4(AGS)
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The choice of the non-linear material is very important for a given application, not only
should the material be as transparent as possible to the IR wavelengths in order not
to introduce thermal noise, but it should also be able to phase match the non-linear
process while preferably having a high non-linear coefficient for efficient frequency
conversion.
So far lithium niobate (LN) has been the preferred material for upconversion detection.
It has been used in an intracavity configuration both for spectroscopic and imaging
applications. It is, however limited by the transparency range (to below 4.5 µm).
At wavelengths below 12 µm, silver gallium sulphide (AGS) has been used both for
imaging [75] and spectroscopy [78]. AGS has very poor thermal conductivity, however,
limiting its potential for intracavity configurations. In imaging applications thermal
lensing within the crystal can cause distorions in images. Silver gallium selenide
(AGSe) might be an alternative for longer wavelengths as well. AGSe can only be
phase matched with longer mixing wavelengths, from 1.9 µm upwards. Consequently
it needs to be combined with InGaAs detectors rather than Si detectors, thereby
increasing the overall cost and complexity of the system.
Upconversion detection has also been demonstrated using periodically poled LN
waveguides (PPLN-W). Comparing PPLN-W with upconversion in the bulk non-linear
crystals, high internal conversion efficiency in PPLN-W can readily be achieved even
with modest mixing powers due to the spatial confinement of the interacting fields
inside the waveguide [73, 79]. If a broadband illumination source is used, the spectral
resolution of the system can be set by the phase matching properties of the non-linear
process.
For an upconversion imaging set-up, the spatial resolution is primarily determined
by the beam diameter of the mixing field. It serves as a soft aperture in the imaging
system. Both the spatial and spectral resolution of the imaging system depend on the
IR input wavelength [74, 80].
Upconversion detection has a very small acceptance angle, which can strongly inhibit
the ambient noise. In contrast, conventional detectors need a cold shield to block the
ambient radiation from almost 2π solid angle.
A potential source of noise for upconversion systems is false MIR photon generation
through a spontaneous parametric down conversion process (SPDC). These MIR
photons are indistinguishable from the signal MIR photons. The upconverted SPDC
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noise is roughly quadratically proportional to the pump power. This results in pump
power having a trade-off term between high conversion efficiency and low-noise.
Further techniques utilising quantum phenomena with potential to improve MIR
imaging technology are induced quantum-coherence imaging [81] and field-resolved
spectroscopy [82, 83], although they have not been applied to real world samples
yet.
2.4 Mid-Infrared Micro Spectroscopy
The spatial resolution of an IR microspectroscopy setup is defined by the wavelength
and the collection optics in combination with the pixel size of the camera.
The choice of the optical setup is heavily dependent on the light source and detection
system. For incoherent light sources such as a globar, the use of reflective optics
is generally considered favourable. Most commercial FTIR microscopes employ
Schwarzschild optics [84] which consist of a matched pair of Cassegrain objectives
(figure 2.4A).
The Cassegrain objective has a central convex mirror that is held in place by a spider
mount reflecting the incoming beam onto a secondary concave mirror above it. The
secondary mirror focuses the beam onto the sample. This configuration can correct
for spherical aberration, coma and astigmatism over a wide range of wavelengths [85].
Moreover, the Cassegrain objective can be used as a solid immersion objective, with
higher magnification and higher numerical aperture than common lenses by the use of
a high-refractive index crystal e.g. germanium (n ≈ 4), hence increasing the spatial
resolution [86].
Reflective optics only suffer from minimal broadband absorptions and thus usually
give higher flux than refractive optics. Furthermore, they are not subject to chromatic
aberrations. Therefore, Schwarzschild optics have proven to be most economical for
non-coherent imaging. The central mirror and the spider legs holding it in place,
however, can cause obscuration of the image, which is negligible for incoherent light
sources but can be a problem with coherent ones [87]. Coherent light sources usually
have higher brilliance, leading to more intense focused beams. Therefore, some losses
due to lower optical throughput of refractive optics can be tolerated when considering
the gain in imaging quality using these sources. Furthermore, the benefit of not having
obscuration outweighs the loss of flux.
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Figure 2.4: Schematic diagram of three distinct optical configurations for MIR hyperspectral
imaging. The beam path is outlined in red lines and the central obscuration in green lines.
A: Set of Schwarzschild objectives used in transmission mode. B: Schwarzschild objective
used in transflection mode. C: Combination of Schwarzschild objective with ATR crystal for
total internal reflection mode
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MIR microspectroscopy can be realised in three different configurations, as shown
in figure 2.4. In transmission mode, the sample is illuminated via a condenser and
the transmitted light is collected in forward direction by a second objective (figure
2.4A). Here, the relevant optical path length is given by the thickness of the sample.
To collect light in backward configuration, samples can be mounted onto reflective
substrates, so that the one objective serves as focusing and collection optic at the
same time. The beam is focused onto the sample, is reflected by the substrate, passes
the sample a second time and is collected by the objective (figure 2.4B).In this case,
the optical path length is twice the thickness of the sample.
The third way to realise imaging is by attenuated total reflection (ATR) using a high
refractive index crystal as an internal reflection element, (IRE). For this purpose, an
ATR crystal is placed in contact with the sample, and the IR beam is directed into
the crystal and is internally reflected at the interface between the crystal and the
sample (figure 2.4C). This results in an evanescent wave propagating orthogonally
to the surface into the sample. Some of the energy of the radiated field is absorbed
by the sample, resulting in an attenuation of the light reaching the detector. When
the critical angle (Θc = sin−1(n2/n1)), where n2 and n1 are the refractive indices
of the sample and the crystal, respectively) is exceeded, a purely ATR spectrum is
observed. In this configuration, the optical path length depends on the refractive index
of the ATR crystal. Valuable reviews have been published by Kazarian and co-workers
on advances and applications of ATR-FTIR spectroscopic imaging to biomedical
samples [88, 89], and pioneering work in biomedicine [90] includes the application of
this technology to the studies of atherosclerosis [91–93].
The choice of sampling mode has major influence on the sample preparation required.
Imaging in ATR mode requires the least sample preparation as the crystal is simply
pressed onto the sample. The effective sampling volume depends on the internal reflec-
tion elements refractive index (n1), the samples refractive index (n2), the wavelength
(λ) and incident angle (Θ) The penetration depth of the IR beam is given by equation
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Transmission and transflection modes however require the sample to be mounted
on a transmissive or reflective substrate. For transmission mode, monocrystalline
calcium fluoride (CaF2) or barium fluoride (BaF2) slides are the optimal substrate.
These substrates are expensive (>100$/slide) and brittle. Transflection measurements
require reflective substrates. The most common way to achieve this is by coating
glass slides with either gold or a low-emissivity (low-e) coating consisting of a very
thin aluminium layer covered by a thin oxide layer. Those substrates are cheaper
(< 5$/slide) than the monocrystalline ones commonly used for transmission IR.
Apart from the difference in the sample preparation, the sampling geometries can
cause different effects in the spectra. Whereas influential factors on the image itself
are well understood, there are furthermore important effects with regard to the
spectral domain, which are less recognised. The aim in MIR imaging is to obtain
transmission/absorption spectra from the samples. In the microscopy case, this
aim can be perturbed by the fact that features of interest are of the same order of
magnitude in size as the wavelength used for probing. Therefore, Mie scattering [94]
can be observed in some cases. Bassan et al. developed an algorithm to correct for
spectral distortions caused by Mie scattering, also incorporating resonance effects [95],
i.e. related to the change in imaginary refractive index at spectral absorbance peaks.
The algorithm has recently been further optimised by Konevskikh et al. [96, 97].
In transflection sampling, a different type of spectral distortion first referred to
as electric field standing wave effect (EFSW) was reported by Bassan et al. [98],
Filik et al. [99] and Wrobel et al. [100, 101]. A rigorous investigation of the theory
by Joe Lee [102] however proposes that these effects are not due to a standing wave
in the classical sense but can rather be explained by interference between reflections
from a variety of different sample planes.
The formation of an image can be achieved in several ways; the two most common
commercially available approaches are wide field imaging and point scanning. In
wide-field imaging, the image is obtained by combining optics with a camera to
obtain spatial resolution [103]. Hyperspectral information can then be obtained by
introducing an interferometer, or wavelength filter into the beam path or by using
a tuneable monochromatic light source and collecting individual images at several
wavelengths. In point scanning, the light is focused into a diffraction limited spot,
which is scanned across the sample [104]. The transmitted or transflected radiation can
then be recorded on a single element detector. Spectral resolution can be obtained in
the same fashion as in wide field imaging as well as by using a diffraction element and
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dispersing the spectrum onto an array or line detector. Note that this latter approach
should be described as mapping rather than imaging. For diffraction limited imaging,
a wide-field approach is easier to realise and usually allows for faster data acquisition
than point scanning. Point scanning systems have a much higher requirement on
mechanical stability and therefore are more difficult to construct. If a coherent light
source is used, a point scanning system is not affected by speckle. The spatial and
phase variation in the beam wavefronts and associated interference are not resolved in
point scanning, as they would be in a wide-field imaging system.
There are major differences in the nature of data obtained by discrete frequency (or
monochromatic) sources and continuous sources. Continuous or broadband sources are
most often used with interferometers, to take benefit from the Felgett and Jaquinot
advantages [105]. In this work, these systems are referred to as Fourier transform
(FTIR) spectrometers and the resulting data as FTIR spectra or data; whereas datasets
of discrete sources will be referred to as discrete frequency IR (DF-IR) data.
FTIR data are essentially hyperspectral images with over 100 frequencies [106]. They
also have the property that the bands are highly contiguous, while DF-IR images
generally consist of images at much less than 100 discrete wavelengths. For hyper-
spectral images this means that each pixel can be represented as a spectrum, while
for DF-IR or multispectral images this is not always the case. A comparison between
hyperspectral and multispectral images is shown in figure 2.5.
The contiguous nature of the bands in IR spectra forming hyperspectral images allows
application of a range of multivariate analysis techniques to extract the relevant
chemical information. A hyperspectral dataset can be thought of as a data cube, with
two spatial dimensions (x, y) and one spectral dimension (z). By unfolding the cube
into a two-dimensional array, where each row represents the spectrum recorded for a
single pixel, standard multivariate approaches can be applied. Refolding the processed
array into a cube allows visualisation and interpretation of the data in the image
domain that may not be possible otherwise, while the multivariate analysis allows for
interpretation in the spectral domain, as well.
Absorption of radiation occurs at IR frequencies that match the vibration frequency
of chemical bonds in the molecules of the sample. The transmittance or proportion of
light transmitted through the sample, T , is calculated as the ratio of the intensity of
light passing through the sample I to the intensity of a background or blank I0. In
CHAPTER 2. MID-INFRARED TECHNOLOGY 23
2.4. Mid-Infrared Micro Spectroscopy
Figure 2.5: Illustration of (A) a multimodal multispectral image and (B) a single mode
hyperspectral image. (C) and (D) are the intensity profiles for the pixels indicated in (A)
and (B), respectively.
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microspectroscopy, the background is typically a clean area of the transparent slide or




The transmittance is related to absorbance by a simple logarithmic transform:





= − log10(T ) (2.8)
Multivariate analysis commonly assumes the Beer-Lambert law to be valid for this
application. It states that the absorbance A at a given wavelength is proportional to
the analyte concentration c:
A(λ) = a(λ) · b · c (2.9)
where a(λ) is the wavelength dependent molar absorption coefficient of the sample
material and b is the optical path length. Many multivariate approaches assume linear
relationships between variables, and using the Beer-Lambert law the results can be
interpreted in terms of concentration. This provides quantitative analysis for the
absorption spectroscopy data.
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Disclaimer: This chapter is an adaptation from a review paper entitled: ‘Mid-IR
hyperspectral imaging for label-free histopathology and cytology‘ publish by the author
of the thesis and collaborators in the IOP journal of optics [1]. The review is published
licensed under Creative Commons Attribution 3.0 licence which allows reuse and remix
of content. The following chapter is remixed from sections: 5. Hyperspectral data
analysis and 6. Biomedical applications. The descriptions of EMSC; PLS and LDA
have been further elaborated from the review paper as these techniques are most relevant
to this work.
3.1 General Spectral Preprocessing Methods
A number of preprocessing steps are often required prior to undertaking detailed
multivariate analysis of hyperspectral images in order to obtain meaningful results
and interpretation. This section focuses on methods to analyse the spectral domain
i.e. the unfolded data cube. These techniques have been developed in the context of
FTIR data and some of them harness the continuous nature of the data, therefore
application to DF-IR has to be considered with caution.
3.1.1 Normalisation
A key assumption when using the Beer-Lambert law is that the optical path length
b (and molar absorption coefficient) is the same for each pixel. For histopathology
applications, where the sample is a tissue section cut by microtome, variations in the
sample thickness across the section result in a different path length. A normalisation
step is therefore essential for comparing variations in absorption between pixels in an
image. One simple approach is vector normalisation, which maps the spectra onto
a unit sphere in multivariate space [107]. Other approaches include normalisation
to constant total [107] and min-max normalisation, which scales each spectrum to
between 0 and 1. Normalisation, however can have the disadavantage, especially
26
3.1. General Spectral Preprocessing Methods
in imaging, that pixels with lower signal will be given less weight. This propagates
to subsequent multivariate analysis, potentially masking important variations of
compositional changes related to pathology.
Another common approach to normalisation in MIR spectroscopy is Multiplicative
Scatter Correction (MSC) [108]. It attempts to account for scaling and offset effects
by calculating a least-squares-fit of the measured spectrum to a reference spectrum.
The measured spectrum is then corrected, the using the slope and offset of the fit.
Extended Multiplicative Scatter Correction (EMSC) has been described that allows
for normalisation, baseline subtraction and filtering of unwanted signals in a single
step [109, 110]. Examples of application of EMSC in histopathology include Resonant
Mie Scatter EMSC (RMieS-EMSC) [111] and paraffin removal [112, 113].
Standard Normal Variate (SNV) has also been suggested as an alternative method for
normalisation [114]. SNV centres a spectrum and scales it by its own variance. SNV
gives more weight to values in the spectrum that deviate most from the mean value,
which for FTIR corresponds to peaks in the absorbance spectrum. It is usually most
successful when the spectra are quite similar e.g. between pathology groups. It has
been shown that SNV and MSC are mathematically very similar [115, 116].
3.1.2 Baseline Subtraction
In some cases there is unwanted background signal in the spectra forming an image.
Specific approaches for background removal of signals due to atmospheric water vapour
and resonant Mie scattering are discussed separately. For more general problems
involving an undulating baseline, a polynomial subtraction approach can be used
to subtract a best fit of the baseline. An iterative refinement of this approach is
described in [117]. Sometimes the baseline will be too complex and a polynomial will
not be capable of fitting the baseline without resorting to high orders that will over
or under correct in some areas while fitting well in others. Approaches such as the
rolling ball algorithm [118] and asymmetric least squares [119–121] may then be more
appropriate. A comparison of various baseline methods for spectroscopic calibration
has been published by Liland et al. [122].
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3.1.3 Derivative Spectra
In microspectroscopy for histopathology the complexity of the sample, consisting of
potentially thousands of biochemical signatures, results in highly complex IR spectra
with multiple overlapping peaks. A common and highly successful approach is to use
derivative spectra; the use of 2nd order derivative spectra is particularly prevalent [123].
This has two advantages: firstly, some baseline is removed without resorting to the
methods described earlier (though this is limited to the derivative order minus one)
and secondly it emphasises the shoulders of broad peaks when applying multivariate
analysis. Disadvantages include making interpretation of subsequent analysis more
difficult and emphasising noise. A Savitzky-Golay filter [124] is often used to calculate
the second derivative and has the added advantage of smoothing at the same time,
thereby reducing the impact of noise.
3.2 Specific Preprocessing Methods in Biospectroscopy
3.2.1 Atmospheric Water Vapour Removal
It is common practice to equip FTIR instruments with desiccant and a purge box
to reduce the effect of absorption peaks from the atmosphere, in particular water
vapour and carbon dioxide (CO2). Fortunately, the position of the CO2 peak at
2300-2400 cm−1is well outside the typical ‘fingerprint region‘ and ‘high wavenumber
region‘ (1000-1800 cm−1and 2600-3800 cm−1, respectively) and this region can simply
be excluded. The effect of water vapour is however more serious as it overlaps with the
fingerprint region, has numerous sharp peaks (associated with the rotational structure
of the vibrational bending and steching modes) and is highly variable. Research is
ongoing to explore methods to compensate for the presence of water vapour in the
spectrum [125–127], and there have been some successful applications [128]. Perkin
Elmer includes a patented method for Atmospheric Vapour Compensation (AVC)
in the software for their FTIR systems that is based on a simulated water vapour
spectrum with very high spectral resolution [129, 130].
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3.2.2 Resonant Mie Scatter Extended Multiplicative Scatter Correction
(RMieS-EMSC)
A known problem when using MIR spectroscopy to examine biological samples,
particularly cells, is that the light has a similar wavelength to the diameter of particles
(or cells) in the sample. This causes scattering, known as Mie scattering, which
appears as a strong sloping baseline in the spectra of the sample. The scattering
also contributis to distortions in the spectral peaks (with artefacts such as derivative
shaped absorbance bands) resulting in small shifts in the peak wavenumber positions of
important biomolecules such as proteins, making peak assignment and interpretation
unreliable. In histopathology and cytology samples, the total Mie scatter is generated
by contributions from a range of particle sizes and other properties making it difficult
to compensate for.
Several attempts have been made to correct for Mie scattering contributions to FTIR
spectra [131, 132], but the most popular approach uses a model for Mie theory that
includes resonance [95]. First published in 2010 [111], the RMieS-EMSC algorithm
incorporates a principal component model of resonant Mie scatter spectra generated
from a theoretical basis into the standard EMSC algorithm as an interferent matrix
(see below). Because the calculated scatter depends on the input spectrum, repeated
applications of the algorithm have been shown to improve the correction but at the
expenses of a considerable increase in computation time, particularly for hyperspectral
datasets that contain tens of thousands to millions of spectra. An approach using
graphical processing units (GPUs) to parallelise the correction algorithm has been
suggested as a way of mitigating this problem [111], but currently adds a level of
complexity and expense that might prevent clinical uptake.
3.2.3 Paraffin Removal
Motivated by the need to work with the current histological pathway, which involves
formalin fixed, paraffin embedded tissues, some research groups have examined the
possibility of using paraffin embedded sections. Some studies have used fresh frozen
tissue because paraffin wax has a strong FTIR spectrum with peaks in the fingerprint
region. Approaches investigated so far include chemical removal of paraffin using
solvents such as xylene and hexane [133, 134] or chemometric methods that involve
an EMSC step with a principal component model of paraffin wax spectrum as an
interferent matrix [112]. Nallala et al. demonstrated that the EMSC approach is as
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good as or better than the chemical removal of the paraffin contribution to FTIR
microspectroscopy data of human colon tissue sections [113].
The EMSC utilises prior chemical knowledge of the samples by feeding in reference
spectra for paraffin. It decomposes a measured spectrum (Zn×p) assuming it consists
of a linear combination of ‘theoretical‘ spectra representing the chemical composition
of the sample.
A single spectrum therefore, is decomposed into ‘theoretical‘ spectra (Z(n×i)chem ) referred
to as loadings and scores an of those components (B(n×i)), as well a residual error
term E(n×p):
Zn×p = B(n×i)Z(n×i)chem + E(n×p) (3.1)
The index i denotes as the total number of components used for modelling, n denotes
as the number of data points per spectrum and p is the number of spectra which are
corrected. If any pure component spectra are known, they can be directly used for
modelling; otherwise, they can be estimated using a principal component analysis or
similar technique. Zchem can be decomposed into a part worth retaining (Zretain) and
one to discard (Zdiscard). Since only Zretain needs to be retained equation 3.1 can be
rewritten as:







If Zretain is retained, any wavelength dependent changes can be corrected and contri-
butions from perturbation components such as paraffin can be removed. Furthermore,
the B term can be utilised to estimate concentrations of the components in Zchem [135].
A more detailed introduction of EMSC and related techniques can be found in [136,
pp. 139-160].
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3.3 Visualisation and Exploratory Analysis
Although all of the multivariate methods described in this introduction ignore spatial
information, it is still advantageous to interpret the information in the image domain
in order to give some biological context. For example, it would be very difficult to
identify a spectrum as being from a cell nucleus if it is not possible to see it in the
context of the surrounding cell. The following methods are the most commonly applied
for microspectral histopathology.
3.3.1 Intensity Based Images
Any approach that generates a value ‘per pixel‘ can be used to visualise a hyperspectral
image by refolding the result into an array with the same spatial dimensions as the
original hyperspectral image. For example, maximum intensity, intensity at a single
wavenumber or a fit coefficient from EMSC can all be used to generate intensity-based
images. A false colour image can then be obtained in order to allow interpretation.
Care should be taken to ensure that outlier pixels and the chosen colour table or bar
do not unduly influence the visualisation and interpretation of the image [137]. Colour
tables with discrete step changes in colour, rather than shade, should be discouraged
for this reason.
3.3.2 Principal Components Analysis (PCA)
PCA is a data reduction technique that decomposes a dataset into a set of linearly
uncorrelated variables called principal components (PCs) [138, 139]. PCA is useful
in hyperspectral image analysis [140] because it provides information about the
pixels in the form of principal component scores and the corresponding biochemistry
in the loadings (see section 3.4.1 for mathematical details). Because the scores
for each component are per-pixel, they can be refolded into intensity images (see
figure 2.5). In addition, examining the loadings for that component alongside the
scores-based intensity image allows interpretation in both spectral and image domains.
For histopathology applications, this enables spectral differences between pathology
groups, for example, to be discussed in terms of biological structures in the tissue
section. This is vital for comparison with standard histology that relies almost entirely
on interpretation of the biological structures and only uses the biochemistry as a
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means to improve image contrast through the application of chemical stains such as
haematoxylin and eosin (H&E).
PCA outputs are the principal components listed according to a decreasing order
of explained variance. Alternative approaches include Minimum Noise Fraction
(MNF) [141, 142] and Min/Max Autocorrelation Factors (MAF) [143] which order the
components by signal-to-noise ratio.
PCA is applied as a processing method or, more often, as a preprocessing step before
a classification method such Linear Discriminant Analysis (LDA) or Support Vector
Machines (SVM) is applied. Including a PCA step reduces the influence of noise (by
excluding components) and prevents over fitting by reducing the number of variables
in the model, by combining those collinear variables found in the dataset together in
one principal component, leaving only orthogonal components.
3.3.3 k-means Clustering
k-means clustering is an exploratory algorithm that aims to divide the spectra into k
groups, or clusters [144]. Each spectrum belongs to the cluster with the nearest mean,
or centroid. Its primary use in hyperspectral imaging is as a form of visualisation.
Clustering creates a new vector that contains a value indicating the cluster membership
of each pixel. An image can then be generated by shading each pixel according to its
cluster membership. In image processing terms, the image has been segmented and is
now easier to interpret. For histopathology applications, not all of the clusters will
be relevant and all spectra associated with those clusters can now easily be removed
from further analysis.
k-means clustering does have some disadvantages. For example, it can be difficult
to choose an appropriate value for k i.e. the number of clusters. Too few and
the segmented image is not informative, too many and the clusters represent noise.
Methods such as the silhouette width [145] exist to try and solve this problem but are
often computationally intensive and can overestimate, or underestimate the number
of informative clusters.
In histopathology applications, in particular, the value of k that generates meaningful
clusters biologically is often much larger than the number determined by the silhouette
width. Other disadvantages include initialisation, which may result in different
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clustering each time the algorithm is applied to the same image, and the inability to
use any distance measure other than the Euclidean distance.
Modifications such as k-mediods [145] have been proposed to allow for the use of
alternative distance measures, and other extensions are available such as Fuzzy C-
Means (FCM) [146, 147]. They allow for soft-cluster membership i.e. each pixel has
some degree of membership to all clusters. Spatially-guided FCM (sgFCM) [148] takes
into account both the spectral and spatial information during clustering.
Furthermore, clustering performed on separate hyperspectral images often leads to
regions with similar spectral signals being allocated to clusters with spectrally different
centroids and colours in the different images. Common k-means on the whole dataset
can overcome this problem at the expenses of significant computing resources. Self-
Organising Maps (SOM), an unsupervised neural network [149], has also been used as
alternative form of clustering for microspectral histopathology [150].
3.4 Predictive Modelling
A longstanding goal of microspectral histopathology has been to make predictions
for the detection of disease. In a data analysis context, this is usually framed as
a classification problem. Applied approaches include Linear Discriminant Analysis
(LDA) [107], Partial Least Squares-Discriminant Analysis (PLS-DA) [151, 152], Support
Vector Machines (SVM) [145, 153], Random Forests (RF) [154] and Neural Networks
(NN) [155]. In this thesis only Partial Least Squares Linear Discriminant Analysis
(PLS-LDA) has been used and therefore will be explained in greater detail in the
following. For the understanding of PLS the concept of Principal Component Regession
(PCR) is crucial and hence PCR is explained first.
3.4.1 Principal Component Regression (PCR)
A Principal Component Analysis (PCA) as briefly explained in section 3.3.2 can be
used to extract latent variables from a high dimensional space.
To apply PCA to a set of spectra, the spectra need to be expressed as matrix. Assuming
an ideal and noise free case this matrix (X) would be expressed as linear combination
of the spectra from pure components (S) and their concentrations (C):
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X = C× S (3.3)
Hence, the rank of X is defined by the number of components (number of spectra in
X). If there are more spectra in X than in S equation 3.3 becomes an overdetermined
system. In this case S as well as C can be estimated from X if the chemical rank
given by the number of components is smaller than the numerical rank (more spectra
measured then different chemical components present).
PCA allows to perform such a decomposition of X on real data which has noise in
addition to the chemical components. It is important to note however, that the results
of PCA are not equivalent to real pure component spectra and actual concentrations.
PCA is usually performed on centred spectra (Xc = X−RowMean(X)). The decom-
position leads to expressions relatively linked to Xc. PCA is essentially performed as
a singular value decomposition (SVD) used in various other mathematical approaches,
as well.
SVD performs an orthogonal basis transformation of Xc. The new basis is to maximise
the variance covered by each axis. The transformation results in latent variables or
loadings (P) which can be interpreted as estimation of the pure component spectra
and scores T which can be seen as estimation of the pure component concentrations:
Xc = T×P (3.4)
T and P consist of an equivalent number of spectra (and scores) as Xc. In addition
to that, an SVD estimates singular values which indicate the variance covered by each
score-loading-pair.
PCA heavily depends on the assumption that the spectra matrix is overdetermined (the
chemical rank is lower than the numerical rank). Thus, relevant features are expected
in the score-loading-pairs which cover much variance whereas the low variance score-
loading-pairs consist of measurement noise. Additionally, an experienced spectroscopist
can interpret spectral features in the structure of the loadings. For a more detailed
mathematical background and examples the reader is referred to the tutorial on PCA
by Jonathon Shlens [156].
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The sorted structure of the loadings allows for feature selection based on the variance
covered. Out of the scores and loadings an estimation of equation 3.3 can be made. The
estimates for the concentrations T′ and for the pure component spectral contributions
P′ are made by selecting the relevant scores and loadings and excluding the rest in an
error term (E):
Xc = T′ ×P′ + E (3.5)
An MIR spectrum consists of hundreds to a few thousand data points. Hence,
the decomposition decreases the number of parameters for regression by orders of
magnitude comparing a PCR with multiple regression performed directly on the
spectra. More information and mathematical background for PCR can be found in
Geladi et al. [157].
3.4.2 Partial Least Squares (PLS) Regression
PCA projects Xc maximising total variance in the first principal components. The
scores obtained by the projection can then be used for a regression to either classify or
quantify. This approach however does not take into account any a priori knowledge
present. Therefore, using a PCR model for classification purposes always implies
the assumption that the main cause of variations in the data set are related to the
modelling problem.
If a priori knowledge of the problem is present by having training data the concept
of PCR can be modified to take this information into account. A Partial Least
Squares (PLS) Regression does this by maximising the shared variance between
measurement data and target variable (class for classification or concentration if used
for quantification). This approach has proven to result in similar or better model
quality than the unsupervised projection during PCR can provide [158].
PLS utilises the nonlinear iterative partial least squares (NIPALS) algorithm for
projection. NIPALS in contrast to SVD, performs sequential extraction of score-
loading-pairs. The extracted pair is linked to the variation in the target variable and
the obtained loading is orthogonalised by introducing weights (W). Each subsequent
extraction is performed on the residuals of the last one. The full mathematical
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explanation of the process can be found in an excellent tutorial by Paul Geladi and
Bruce Kowalski [159].
The PLS approach as described above is only a projection which essentially resorts
the variable space to accumulate the relevant information in fewer variables. In order
to use this for classification or quantification it needs to be paired with a regression
or classifier technique. For spectroscopic data the combination of PLS with a Linear
Discriminant Analysis (LDA) has been demonstrated to provide a robust approach [160,
161].
3.4.3 Linear Discriminant Analysis (LDA)
Linear Discriminant Analysis (LDA) is a classifier based on a projection which max-
imises inter-group-variance while minimising intra-group-variance. For a classification
into N different groups this is done by finding a N − 1 dimensional subspace in the
data set by applying a singular value decomposition on the covariance matrix of
the classes similar to PCA. The mathematical details can be found in the original
article by R. A. Fisher [162]. LDA applied to spectroscopic data on its own without
regularisation however is prone to overfitting [163, 164]. Therefore it is often combined
with either PCA or PLS as discussed above.
3.4.4 Implementations
The approach taken by a number of studies is to generate healthy/normal/benign
vs disease type models using pixels of interest extracted from hyperspectral images.
Selection of these regions of interest is either guided by a pathologist or extracted
using a technique like k-means, or by a preliminary classification model trained to
identify different tissue types (e.g. stroma), or a combination thereof. The predicted
pathology labels can be generated on a per-pixel basis and refolded for visualisation
in a similar approach described previously for k-means. Figure 3.1 shows an example
human colon section where the red and green pixels are the outputs of a predictive
algorithm to detect cancer. Black pixels have been rejected as ”not-epithelium” and
white pixels indicate the substrate, or absence of sample.
36 CHAPTER 3. HYPERSPECTRAL DATA ANALYSIS
3.5. Chemometric Analysis of Discrete Frequency IR Images
3.5 Chemometric Analysis of Discrete Frequency IR Images
Using FT-IR imaging is popular because use of the Fourier transform allows rapid
collection of the entire spectrum. For biospectroscopy applications though there are
regions of the spectrum that are not informative, either because they only contain
noise or because they do not provide relevant information e.g. indicating the presence
of disease. DF-IR has been proposed as an alternative that only collects IR images at
specific (‘discrete‘) wavelengths that are relevant to the problem being studied.
In general, the number of relevant wavelengths is expected to be far lower than those
in a whole FTIR spectrum, and thus using DF-IR may speed up image acquisition,
which is critical for translation of MIR imaging into histology applications. Because
of the complexity of the samples in biospectroscopy, relevant targets for DF-IR
imaging typically fall into bands, or blocks, covering regions of overlapping peaks that
correspond to biologically important molecules such as proteins or lipids.
Thus, DF-IR imaging falls somewhere between multi- and hyper- spectral imaging.
As such, many of the approaches described before, which work well for hyperspectral
images, may no longer be suitable for DF-IR images. Alternative normalisation
methods such as autoscaling (standardisation), or block scaling, will be more suitable
due to the discrete nature of the wavelength regions being collected. Research is
ongoing in this area as new instrumentation for collecting DF-IR images becomes
available.
For DF-IR imaging to be successful, the right wavelengths have to be measured. The
approach generally taken in the literature so far relies on FT-IR imaging combined
with variable selection methods to identify the relevant wavelengths for a particular
problem. A number of variable selection methods are available for this purpose,
and some recent examples for wavenumber selection in DF-IR imaging include Gini
coefficients [12] and Variable Importance in Projection (VIP) scores [165].
Whichever method is used, a robust validation scheme is required to prevent overfitting
and accidental selection of non-informative wavelengths, both of which would be
detrimental to translation of DF-IR into clinical applications. Ultimately, the selected
wavenumber targets have to be tested using a large external validation set to verify
their suitability for a given problem. The problem-specific nature of wavelength
selection requires the selection to be applied afresh for every research question.
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Figure 3.1: Comparison of (left panel)
different visualisation methods for hy-
perspectral imaging versus (right panel)
a standard histology stain for columnar
glands.
MIR transmission profiles were first consid-
ered as valuable for diagnostic purposes in
1949 by Blout and Mellors [166] who ob-
tained bulk spectra from tissue sections and
blood smears. Since then research in this
field did not really progress until the 1990s
when FTIR microspectrometers became avail-
able [167]. Although tremendous progress
in imaging technology has been made over
the last decades [168], histopathological diag-
nostic routines have changed very little over
the last hundred years [133, 169]. This could
change soon with concepts of digital spec-
tral pathology as pointed out in an excellent
review by Bhargava and Madabhushi [170].
This section provides an overview of the cur-
rent research on MIR imaging technology for
biomedical diagnostics. Focus lies on imaging
tissue sections and cells. Further interest is
increasing in the analysis of biofluids, or liq-
uid biopsies, which is outside the scope of this
introduction, but the reader is directed to a
review by Baker et al. [4] for more information
on this.
As already discussed in the data processing
section, IR hyperspectral images are directly correlated with the underlying biochem-
istry of the sample. Plotting metrics computed from IR spectra can be described as
‘digital staining‘ i.e. an alternative to the chemical stains currently used in histopathol-
ogy. Digital staining has the potential to provide more information than current
chemical staining technologies. Increasingly complex information can be generated by
treating three different intensity based images as a single RGB image. An example
is shown in figure 3.1 which is the composite image of three selected principal com-
ponents. One criticism of this approach is that the pseudo colour maps can be too
colourful, which some pathologists may find off-putting. A suggested alternative is
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to use approaches such as neural networks to generate images that look more like
stained images and provide the equivalent of a chemically stained image without
any chemical staining; so called stainless staining (124). An example using a PLS
regression model to digitally stain a colon section is shown in figure 3.1. Advantages
include visualising multiple stains for the same section and otherwise impossible stains
e.g. for biomarkers or pathology indicators that do not currently have a chemical stain.
The primary disadvantage is the decreased spatial resolution in IR images versus the
visible, because of the longer wavelengths involved and the corresponding diffraction
limit.
Digital staining, however, still relies upon a pathologist to interpret the resulting
spatial distribution of biochemical signals as they would for conventional chemical
staining, although each unstained section could be digitally stained for various different
biomolecules of interest. The true benefit is gained by predicting pathology directly
from the combined chemical and spatial information. Old et al. demonstrated
classification accuracies of 100 % while denying decision for 30 % of the samples for
the diagnosis of oesophageal adenocarcinoma [171]. Tiwari et al. described the use
of a QCL microspectroscopy setup for the identification of infiltration and fibrosis
in endomyocardial biopsy samples to assess transplant rejection, achieving 82.87 %
overall accuracy without neglecting samples [104]. There are numerous more examples
of proof of concept experiments achieving classification accuracies between 70 and
95 % [8, 12, 172–181].
The most common problem in this research however is that sample numbers are
usually relatively small which makes classification models susceptible to the curse of
dimensionality [170, 182]. If a single spectrum consists of more data points than there
are samples, classifiers have significant chance of picking up random variations as
features for classification. This can be overcome by applying dimensionality reduction
methods such as PCA or increasing the sample size. Higher sample numbers however
are difficult to collect, measure and analyse. A common shortcut, here, is to utilise
tissue micro arrays (TMA) which are paraffin blocks consisting of selected biopsy
sub-sections from different samples arranged in an array specifically used for medical
research. Individual sections can then be taken that include cores of many tens to
hundreds of tissues samples. This provides a good distribution of tissues, pathologies
and patients, and it is simpler for the pathologist to classify each sample. The
disadvantage of this is that it does not represent the large samples and variance found
within individual samples that a pathologist would usually make their diagnosis from.
A very good example of utilising TMAs for this purpose is given by Bhargava et
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al. [183]. Another big challenge in the field is to find a uniform approach for data
acquisition, to make use of the spectral information, suppressing perturbation from
individual instrument response functions [184].
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4.1 Anatomy: The Physiological Oesophagus
Figure 4.1: The gastrointestinal tract [185].
The oesophagus is part of the gas-
trointestinal tract as depicted in Figure
4.1 [185]. Its primary function is to trans-
port food from the mouth to the stomach
for digestion. Its structural features can
be classified in several different ways de-
pending on the context. In this thesis a
classification based on the microanatomy
is most useful. Alternatively, it is also
common to segment the oesophagus by
its constrictions which is more convenient
in a surgical context.
The five main structural features consti-
tuting the oesophagus (see Figure 4.2)
from the inside to the outside are:
(1.) The Lumen which is the cavity food
is transported through, facing (2.) the
Mucosa, the innermost lining made of the
mucous membrane. This layer of epithe-
lium is followed by the Lamina Propria ,
a layer of connective tissue about a third
of the thickness of the epithelium. It
finishes with the Muscularis Mucosae, a
slim layer of smooth muscle. (3.) The
Submucosa is located on the outside of the Mucosa. The term describes a layer of
dense connective tissue housing blood vessels, mucous glands and lymphatic tissue. It
is followed by (4.) the Muscularis Propria, two orthogonal layers of muscle responsible
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for the propulsive motion transporting food to the stomach. The outermost layer is
the (5.) Adventitia, made of connective tissue [186].
For the purpose of this thesis it is important to see these structures in relation to
their observability. At the current state of the art, infrared imaging techniques1 can
resolve tissue samples in the 1–10 µm regime. Individual biological cells as can be
found in the oesophagus are on the same scale. Therefore, the cellular dimension of
the different layers of the oesophagus needs to be discussed in more detail.
Figure 4.2: Layers of the oesophagus.
The Lumen essentially being a void, does not have any cellular features. There are
stratified non-keratinizing squamous cells in the mucous membrane of the Mucosa.
The lack of keratin however makes these cells less resistant to the mechanical strain
than keratinized cells (e.g. skin). This leads to a high rate of cell loss by abrasion
during the process of transporting food. To compensate for this, the epithelium
is consistently regenerating itself from the basal to the superficial layers. In order
to achieve consistent growth, the cells need to be connected to the nervous system
1Nano/nearfield imaging will not be discussed in this context as they are not capable to image large
enough areas to be of histopathological relevance at this time.
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and the blood supply. Cell division is most active in the basal layer of the mucous
membrane facing the Lamina Propria. In this layer the cells are round and densely
packed. Towards the Lumen they become flatter and level out.
The Lamina Propria is the structural interface connecting the Mucosa to the nervous
system, the lymphatic system and the blood supply. It also houses the oesophageal
cardiac glands and the ducts of the mucous glands which secrete mucus to lubricate
the lining of oesophagus. Structurally the Lamina Propria consists mainly of loose
connective tissue containing some lymphocytes, mostly helper T cells, plasma cells,
and occasional eosinophils and mast cells. Large proportions however are extra-
cellular matrix which consists mostly of collagen and other structural proteins like
fibronectin.
The Muscularis Mucosae separates the Lamina Propria from the Submucosa. It is
composed exclusively of smooth muscle cells. The muscle is in constant motion to
ensure contact between the mucous membrane and the content of the Lumen during
swallowing as well as supporting the secretion of the glands to keep the oesophageal
lining lubricated.
The Submucosa is a layer of dense connective tissue adjacent to the Mucosa. It
includes blood vessels, mucous glands and lymphatic tissue. It also houses Meissner‘s
plexus, a collection of Dogiel cells which provides nerval innervation towards the
Muscularis Mucosae and to the mucous membrane.
The Muscularis Propria consists of muscle cells oriented in a circular and a longitudinal
coat. Controlled contraction of these muscles causes the propulsive motion transporting
food to the stomach. Furthermore, the Muscularis Propria houses Auerbach‘s plexus,
the biggest nervous node connecting the nervous system to provide motor and sensory
innervation for the oesophagus.
The Adventitia is the outermost layer of the oesophagus and is built of coarse connective
tissue. It creates the rigid structure of the oesophagus. The intestines, in contrast to
the oesophagus, have a serosa which allows unhindered movement of the intestinal
loops [186].
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There are several known risk factors for the development of oesophageal cancer. The
two most common types of cancer are squamous cell carcinoma occurring in the upper
oesophagus and adenocarcinoma occurring in the lower oesophagus.
Squamous cell carcinomas are strongly associated with smoking and consumption of
alcohol or very hot beverages which is assumed to cause damage to the squamous cell‘s
nuclei ultimately resulting in cancer. Furthermore, some genetic factors are known,
as well [187]. This PhD thesis however focuses on the diagnosis of adenocarcinomas
and their precursor stages. Oesophageal adenocarcinomas are mainly associated with
gastric reflux.
Gastro-oesophageal reflux disease (GORD) is a common medical condition in western
societies [188, 189]. It is associated with a complex set of risk factors including
life style aspects like obesity [190] and smoking. Conditions like pregnancy or the
need to take certain medication [191] are also considered as risk factors. Under
adverse circumstances GORD can lead to an abnormal change of the oesophageal
lining. Stratified squamous epithelium gets replaced by simple columnar epithelium
with goblet cells which in non-pathological organisms is found in the stomach and
intestines.
The change of cell functionality is referred to as metaplasia and was first observed in
the oesophagus by N. R. Barrett in 1950 [192]. Therefore, it is often referred to as
Barrett‘s oesophagus. The metaplasia itself is not harmful to the person developing
it. The simple columnar epithelium is more resistant to chronic acid reflux from the
stomach and has a protective function for the outer layers of the oesophagus in this
case. Despite its acute protective function for the oesophagus the metaplasia is a
precursor for adenocarcinomas. Patients diagnosed with Barret‘s oesophagus have a
risk of 0.1 to 0.5 % per year to develop an adenocarcinoma [193], which is between 30
to 125 times higher than for the average member of the population [194].
There are also intermediate stages between a benign metaplasia and an adenocarcinoma,
described as dysplasia. Dysplasia again can be subdivided in low and high grade [195].
Dysplastic cells carry damage beyond repair in their genome. This inhibits the tissue
to revert into its original state once the external stress is relieved. Dysplastic cells
are poorly differentiated and bear a high risk to progress into cancer. The grading
of dysplasia however is highly subjective and varies substantially between national
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guidelines [196]. Metaplastic cells in contrast to that are well differentiated and bear
a lower risk for malignant transformation.
4.3 Diagnosis and Treatment of Oesophageal Cancers
4.3.1 Endoscopy
Diagnosing oesophageal cancers in clinical routine is mainly done via endoscopy. The
endoscope used in this procedure consists of a long flexible tube which contains a
camera to allow visual inspection as well as an instrument channel. The instrument
channel can be used to insert a pincer tool with which tissue biopsies can be obtained
for histological examination as depicted in Figure 4.3 (reproduced from [197] with
permission of the rights holder, Elsevier.).
Figure 4.3: Normal oesophagus versus Barrett‘s oesophagus. (A) Normal appearance of
squamocolumnar junction at gastro-oesophageal junction. (B) Normal oesophageal squamous
mucosa. (C) Tongues of Barrett‘s oesophagus radiating orad from the gastro- oesophageal
junction. (D) Biopsy specimen of intestinal metaplasia (arrow points to goblet cell). Repro-
duced from [197] with permission of the rights holder, Elsevier.
The visual differences observable through the white-light channel of the endoscope
between normal (Figure 4.3 A) and Barrett‘s (Figure 4.3 B) can be much more
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subtle than in the depicted example. Therefore, surgeons need years of training and
experience to spot anomalies in a very subjective fashion. If the examiner suspects
Barrett‘s, the guidelines recommend taking at least 8 biopsies [198] to investigate via
histology.
4.3.2 Histology
In the histology laboratory the biopsies are fixed with 3.7 % formalin to prevent
enzymes breaking the tissue down. Then the tissue is washed in solutions of ethanol
and water with a gradient increasing from 70 % ethanol to pure ethanol to dry the
sample. Afterwards, the ethanol is replaced by a solvent (e.g. xylene) miscible with
ethanol and paraffin for optical clearing. Then the tissue is transferred into molten
paraffin at a temperature of 52–60 ◦C. The solvent evaporates and the voids fill with
paraffin which stabilises the tissue for cutting with a microtome once the paraffin
block containing the tissue is cooled to room temperature. The microtome produces
sections of a thickness of 2–20 µm. The sections are floated onto a water bed and
transferred to a histology slide.
As the fixation procedure and chemical treatment deactivates most enzymes and alters
the structure of many proteins, an alternative to this workflow is cryo sectioning if
the biochemistry of the sample is of interest. In that procedure the tissue is snap
frozen and sectioned at -21 ◦C [199]. Fresh frozen sections can be obtained within
minutes after collection of the biopsies whereas formalin fixed paraffin embedded
(FFPE) sections need several hours to be processed. FFPE tissue blocks however are
storable in tissue archives and their sections preserve the morphology of the tissue
better than fresh frozen sections.
The sections of tissue obtained from the microtome or cryotome need to be stained in
order to be assessed by the pathologist. In the majority of cases haematoxylin and
eosin (H&E) staining is performed. Haematoxylin stains acidic structures like DNA
in the cell nucleus blue or purple. Eosin provides contrast to cytoplasmic components
staining them pink (see figure 4.3 C&D).
The pathologist is assessing the H&E stains according to the ‘Vienna classification of
gastrointestinal epithelial neoplasia‘ (see Table 4.1 and indented citation) as reproduced
with permission from the rights holder, Elsevier from [196])
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Table 4.1: Vienna classification of gastrointestinal epithelial neoplasia, reproduced with
permission from the rights holder, Elsevier from [196]
Category 1 Negative for neoplasia/dysplasia
Category 2 Indefinite for neoplasia/dysplasia
Category 3 Non-invasive low grade neoplasia
(low grade adenoma/dysplasia)
Category 4 Non-invasive high grade neoplasia
4.1 High grade adenoma/dysplasia
4.2 Non-invasive carcinoma (carcinoma in situ) 1-150
4.3 Suspicion of invasive carcinoma
Category 5 Invasive neoplasia
5.1 Intramucosal carcinoma 1-151
5.2 Submucosal carcinoma or beyond
For biopsies diagnosed as category 1-negative for neoplasia/dysplasia
(including normal, reactive, regenerative, hyperplastic, atrophic, and meta-
plastic epithelium)-further follow up of the lesion may or may not be
necessary, as clinically indicated. In the case of category 2-indefinite
for neoplasia/dysplasia-follow up is needed because of uncertainty about
the real nature of the lesion. In category 3-non-invasive low grade neo-
plasia (low grade adenoma/dysplasia)-neoplasia is present but the risk
of developing invasive carcinoma is low. Clinicians may consider local
treatment of the lesion or opt for follow up. In category 4-non-invasive
high grade neoplasia-the risk of invasion and development of metastases is
increased. Local treatment such as endoscopic mucosal resection or local
surgical treatment would be indicated. In the case of category 5-invasive
neoplasia-the risk of subsequent deeper invasion and metastases is so high
that treatment is urgently needed and should only be withheld in cases
with clinical contraindications. In general, before a decision on treatment
is made, one should always take into account the possibility of sampling
error which may lead to underestimation of the grade of neoplastic change
or depth of invasion. The histological diagnosis of biopsy specimens is
only part of the total clinical information and should be supplemented by
available endoscopic, radiological, and ultrasonographic assessments of the
depth of invasion.
The following medical treatment of the patient depends on the grading by the pathol-
ogist. If metaplasia is detected, no immediate action is required. The patient is
advised to stay under surveillance [200]. In some cases, medication with proton pump
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inhibitors is administered to stop or delay progression to dysplasia [201]. If dysplasia
is detected by the pathologist, resection, endoscopic radioablation or argon plasma
coagulation is recommended to destroy the dysplastic cells [202, 203]. A major problem
in the field, however, is that grading is still quite variable between observers [10].
A large proportion of adenocarcinoma cases do not need sophisticated diagnostic
routines because patients often already present with symptoms like dysphagia caused
by tumorous stenosis of the lumen when they first contact a physician. In that case
the tumour can be diagnosed endoscopically or using X-ray imaging with barium
sulphate as contrast agent. A resection of the oesophagus is necessary and patient
survival rates are very low because of the advanced stage of disease [204]. Therefore,
more sensitive tools are needed to aid diagnosis and detect these carcinomas earlier.
An excellent overview over the current state of the art and clinical procedure can be
found in the review of Saheen et al. [198].
4.4 Epidemiology
About 10 % of the western world‘s population suffer from some form of oesophageal
disease [188, 189, 205, 206]. The incidence of oesophageal cancer is rapidly increas-
ing [207, 208]. It is currently the seventh leading cause of cancer deaths in the
world [209]. Worldwide, squamous cell carcinoma represents 90 % of the total cases,
but the subpopulation of the western world does have a much higher incident rate of
adenocarcinoma compared to squamous cell carcinoma.
On a global scale, the incident rate of adenocarcinoma per 100.000 person-years is
only 0.7. The western world however has a significantly higher incident rate, with the
UK in particular having an incident rate of 7.2 in men and 2.5 in women. Oesophageal
adenocarcinomas are particularly dangerous as only 20 % of patients survive for 5
years or longer [207]. The main reason for these poor survival rates is the fact that
symptoms only occur once the cancer has progressed substantially. Therefore, most
patients present at a stage where the cancer is already incurable [204]. It is estimated
that only 7 % of cases in the USA are diagnosed through the current cancer control
approaches and therefore more effective screening is needed [210].
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The main focus in developing new approaches lies on providing tools for early detection.
White-light endoscopy is not sensitive enough to reliably differentiate between Barrett‘s
with dysplasia and Barrett‘s without dysplasia which leads to the necessity of taking
biopsies every 2 cm. In addion to being labour intensive and severely inconvenient
for the patient, this protocol is also inefficient. Only less than 5 % of the oesophageal
lining is sampled which causes up to 57 % of dysplasia remaining undetected [211,
212].
4.5.1 Endoscopy
Combining traditional white light endoscopy with confocal laser endomicroscopy (CLE)
has been demonstrated to double the sensitivity to detect dysplasia from 34.2 to
68.5 % [213]. It can however not be used as a standalone technique as it provides a
high false-positive rate of 7.3 % without combination with white light endoscopy [214].
Furthermore, both of these techniques only function as red-flagging methods to guide
biopsies and will not make physical removal of tissue obsolete.
4.5.2 Cytology
A method which does not necessarily require macroscopic removal of tissue is cytology.
Fitzgerald et al. [215] identified Trefoil factor 3 (TFF3) a mucin-associated peptide
involved in multiple biological functions like repair of the mucosa and modulation of
stem cell differentiation can serve as a biomarker to detect Barrett‘s. An immuno-
histological stain has been developed to stain against TFF3 and identify goblet cells
characteristic for Barrett‘s. This can be used in combination with a cell harvesting
device referred to as Cytosponge.
The device consists of a compressed sponge on a string encapsulated in a gelatine
coating. The gelatine dissolves after swallowing which causes the sponge to unfold.
After unfolding the sponge is withdrawn, collecting cells on its way up the oesophageal
lining. The harvested cells are then stained and scored by a gastrointestinal histo-
cytopathologist in a binary fashion as either positive (≥1 TFF3-positive goblet cell) or
negative. This procedure achieved sensitivity of 80 to 90 % in a first clinical trial [216].
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The Cytosponge-TFF3 test is therefore currently tested in a larger trial to evaluate
its feasibility for routine use [217].
Cytological methods in general, however, have the disadvantage that they do not
provide localisation information. Therefore, additional tools are required once dysplasia
or adenocarcinoma are diagnosed to localise them.
4.5.3 Spectral Cytopathology
Diem et al. [218] first demonstrated the use of MIR spectroscopic methods to investigate
cytology samples of the oral cavity and reported promising sensitivities and specificities
of >90 %. This study however consists of only 26 patients which include only 4 tumour
patients and therefore has very little clinical value. Diem et al. followed up with
a second study [219] on Barrett‘s oesophagus cytological samples but again with a
very small set of only 10 patients. Old et al. [220] demonstrated a similar spectral
cytology procedure using MIR spectroscopy on a larger set of 66 patients. The study
reported sensitivity and specificity respectively as follows: normal squamous cells
79.0 % and 81.1 %, nondysplastic Barrett‘s oesophagus cells 31.3 % and 100 %, and
neoplastic Barrett‘s oesophagus cells 83.3 % and 62.7 %. The very low sensitivity
for nondysplastic Barrett‘s, however, deems this approach unsuitably for screening
purposes.
4.5.4 MIR Spectroscopy and Imaging
A small number of studies suggest vibrational spectroscopy could be used on bulk tissue
or histological sections to tackle the issue of relatively high inter-observer variability.
Comparing the results of three different pathologists, a study showed only moderate
agreement between their diagnoses [10]. MIR imaging could be used to reduce this
variability.
The first study to investigate the potential was performed by Wang et al. in 2007
utilising ATR-FTIR spectroscopy to discriminate and classify normal squamous, Bar-
rett‘s, dysplastic and gastric mucosa in fresh-frozen sections [221]. The study sampled
32 patients and detected dysplasia with 92 % sensitivity, 80 % specificity, and total
accuracy of 89 %. Improving inter-observer agreement between two gastrointestinal
pathologists for dysplasia to κ = 0.72 versus κ = 0.52 for histology alone.
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In 2009, Quaroni et al. demonstrated the characterisation of normal squamous, Bar-
rett‘s, and adenocarcinoma tissue samples using FT-IR imaging in FFPE tissue [222].
The study links Barrett‘s to an accumulation of glycoproteins and significant decrease
in glycogen accumulation in the surface layer of the oesophageal lining and suggests
this could be harnessed for diagnostic purpose. This correlation has yet to be proven
however.
In 2012, Amrania et al. demonstrated the use of an MIR imaging system to obtain
digital staining information for diagnostic purposes [223].The study uses an instrument
with filters to collect images at discrete MIR wavelength. The author of this thesis
however cannot see any added value in the results of the experiment compared to a
normal white light microscope. The spatial resolution is worse than standard white
light microscopes and the image contrast obtained is not adding value either.
The most recent study to the authors knowledge by Old et al. developed a machine
learning algorithm to differentiate between normal squamous, Barrett‘s, dysplasia and
adenocarcinoma based on FT-IR imaging data from fresh frozen tissue sections [171].
The study evaluates samples of 22 patients demonstrating 100 % sensitivity and
100 % specificity in discriminating between benign and abnormal types. Neoplastic
Barrett‘s (dysplasia or adenocarcinoma) was identified with 95.6 % sensitivity and
86.4 % specificity.
Furthermore, the start-up ‘beamline diagnostics‘ is developing an FT-IR spectrometer
workflow similar to the method developed by Wang et al. (discussed above) for
diagnosis of oesophageal cancers (http://www.beamlinediagnostics.com/).
4.5.5 Raman Spectroscopy and Imaging
In contrast to MIR spectroscopy which is not applicable in samples with high water
content Raman spectroscopy can be used to analyse clinical samples in vivo. A detailed
comparison between MIR and Raman and assessment of the current state of the art
can be found in a review by Baker et al. [224].
Kendall et al. [10] first demonstrated the use of Raman spectroscopy to differentiate
between normal tissue, Barret‘s and neoplasia in a set of 44 patients. The study
reports sensitivity and specificity for normal 97 % / 99 %; Barrett‘s 84 % / 98 % and
neoplasia 94 / 93 %. Raman microspectroscopic techniques are however very slow
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compared to MIR imaging systems and deliver comparable contrast but slightly higher
spatial resolution.
The author sees main potential for Raman spectroscopic techniques in their application
in endoscopic probes. Ishigaki et al. [225] demonstrated the use of a portable Raman
system to investigate fresh ex vivo samples. They demonstrated sensitivity and
specificity of 81.0 % and 94.0 % for the discrimination of normal from cancerous tissue
in a set of 92 patients.
Bergholt et al. [226] developed a custom-built probe for in vivo Raman spectroscopic
detection of Barrett‘s associated dysplasia in real-time. The probe was engineered to
fit a standard endoscopic biopsy channel. By measuring Raman spectra from surface
lesions before obtaining biopsies they demonstrated sensitivity and specificity of 87 %
and 84.7 %, respectively, for identification of high-grade dysplasia.
As Raman spectroscopy in general suffers from weak signal, several strategies exist
to boost the signal. Feng et al. [227] demonstrated the use of silver nanoparticles
as contrast agent boosting the Raman signal via surface plasmon enhancement.
They investigated paired sections of normal and abnormal tissue of 44 patients.
Microdroplets of silver nanoparticles were added to the sections before measuring
them. This approach achieved an enhancement of the Raman signal demonstrating
differentiation of oesophageal cancer tissue from normal control tissue with 90 %
sensitivity and 97 % specificity.
Another way to amplify the Raman signal is to harness non-linear phenomena like
stimulated Raman scattering (SRS) or coherent anti-Stokes Raman scattering (CARS),
in combination often referred to as coherent Raman scattering (CRS). An overview of
these techniques can be found in a review paper by Schie et al. [228]. Although the
author is not aware of any work with oesophageal samples, one application of CRS
is particularly relevant in this context. Ji et al. [229] demonstrated the use of SRS
microscopy to rapidly acquire in situ label-free pseudo H&E images. Ratio images
of Raman signals at 2930 and 2845 cm−1, reflecting the different lipid and protein
contents, provide contrast to compute images similar to H&E staining.
4.5.6 Digital Pathology
Another emerging trend to improve histological routines is ‘Digital Pathology‘ [170]
which has been demonstrated by Critchley-Thorne et al. in 2015. The team detected
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statistically significant differences between Barret‘s oesophagus biopsies with high
grade dysplasia and nondysplastic biopsies using machine learning algorithms on H&E
images [230].
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5.1 Introduction
Benchmarking imaging systems was first done in a standardised fashion by the United
States Air Force (USAF) in 1951 who developed a standard protocol (MIL-STD-150A).
This procedure was originally developed to test cameras for photography but has been
adapted for the use with microscopy systems. Although the standard is outdated for
photography and was replaced by ISO12233:2017 [231], the USAF chart developed in
1951 (see figure 5.1) is still widely used in microscopy.
Figure 5.1: Original 1951 US air force standard resolving power test target. Reproduced
from [232].
The original target consists of 9 groups, with each group containing 6 elements; thus
there are 54 target elements provided in the full series. Each element consists of three
parallel bars. These 54 elements are provided in a standardised series of logarithmic
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steps in the spatial frequency range from 0.250 to 912.3 line pairs per millimeter.
The series of elements spans the range of resolution of the unaided eye, down to the
diffraction limits of conventional light microscopy. Commercially available targets
usually are printed as metallic chromium on a 50 mm× 50 mm glass slide.
The spatial resolution of an imaging system can be obtained by evaluating the image
of the slide. The spatial resolution defined by the Rayleigh criterion [233] requires
a contrast between a feature and the background of at least 25 %. The size of the
smallest feature which fulfils this requirement can be taken as a measurement of the
spatial resolution of the system. This approach is demonstrated in the following. The
next paragraph is work of the author and was reproduced with permission of the rights
holder, Elsevier from Nallala et al. [234]. It demonstrates the use of a commercially
purchased USAF target to characterise a 25× magnification Cassegrain objective used
on an Agilent Cary 620 MIR microscope:
In order to measure the highest resolution of the system, rather than the pixel size, the
elements 4, 5 and 6 of group 7 on the USAF target were measured using the objective
with the highest numerical apperture (NA) at the highest magnification (0.81 NA
and final magnification of 63×). The lines of this group are separated by 2.76, 2.46
and 2.19 µm respectively. Figure 5.2 shows the images obtained by visualising the
average intensity per pixel of a low wavenumber region (figure 5.2A, 1400–1000 cm−1)
and a higher wavenumber region (figure 5.2B, 3900–3800 cm−1). Figure 5.2C shows a
close-up of the smallest structures (from figure 5.2B) of the USAF target for the region
3900–3800 cm−1and below it the corresponding intensity profile along the coloured
cross sections. The differences in intensity along the cross section show that all of the
structures of the target are clearly resolvable in the high wavenumber region. The
Rayleigh criterion for optical resolution requires a difference in detected intensity of at
least 25% to consider two points being separated is clearly fulfilled for all structures
here [233].
However, this only gives discrete resolution for specific wavelengths and estimating
the resolution of an image when using multivariate analysis of an entire spectrum is
still a subject of ongoing research. The USAF target features of element 6 of group
7 2.19 µm where resolved with a pixel size of 0.66 × 0.66 µm. Further, pixels were
binned to explore how reduction in the sampling frequency affects the resolution of
the USAF target features. For this, pixels from figure 5.2C were binned two times
(figure 5.2D) and four times (figure 5.2E) and their respective intensity profiles plotted
(corresponding plots below figure 5.2D and E, respectively). The USAF target features
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were still resolvable (following the Rayleigh criterion) for figure 5.2D , while the
structures become no more resolvable as can be observed by the loss of the intensity
plot in figure 5.2E.
Overall, the plot shows a decreasing intensity profile for resolving the USAF target
features as the sampling frequency decreases. It has to be noted that the difference in
spatial resolution between the vertical and horizontal axis especially in figure 5.2C, is
an inherent effect caused by the sampling geometry. In transflection mode, only half
of the objective is illuminated by the source whereas the other half of it is used to
collect the transflected light. This effectively results in a lower opening angle along
one of the axis and therefore decreases spatial resolution along that axis.
5.2 Design of a New Microscopy Test Target
The main reason for the USAF target still being used in microscopy, despite being
outdated elsewhere, is that it is easier to manufacture on micro scale and validate.
The modern benchmark targets for photography usually involve patterns with contrast
gradients which can not be manufactured with lithographic methods to this date.
Commercially available chrome on glass targets however do have some limitations and
do not represent a common scenario for bioimaging.
First of all, glass is poorly transmissive in the MIR and therefore prohibits the use of
transmission imaging, which is most often used to image biological materials. Secondly,
chrome is also not an ideal material for spectral imaging in the MIR. It has in general
a very low transmissivity and does not show sharp characteristic features. Thirdly, the
pattern itself can be improved, as the original 1951 USAF pattern is already outdated
for use in photography and was replaced by ISO12233.
These boundary conditions led to designing a new resolution test chart. In order to be
able to use transmission MIR imaging, CaF2 is used as a substrate material instead
of glass. A material with characteristics more suitable to make the features (instead
of metallic chromium) is Polymethylmethacrylate (PMMA). PMMA has a decent
transmittivity and characteristic spectral features. PMMA can be spin coated onto
CaF2 easily. Furthermore, it can be manipulated by electron beam lithography to
obtain detectable features. However, the pattern used for ISO12233 is too sophisticated
to be manufactured by electron beam lithography. Therefore, it was decided to go
back to the original 1951 USAF pattern and adjust it for the purpose at hand.
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Figure 5.2: FTIR image of chrome on glass USAF 1951 target of the elements 4, 5 and 6
of group 7 measured using 0.81 NA infrared objective at 63× magnification corresponding
to a pixel size of 0.66 µm× 0.66 µm. (A) Average intensity per pixel in the region 1400–
1000 cm−1; (B) average intensity per pixel in the region 3900–3800 cm−1;(C) zoomed in area
of the boxed region from B with its corresponding average intensity along the coloured lines;
(D) 2× 2 binned image of C with its corresponding average intensity along the coloured lines;
(E) 4× 4 binned image of C with its corresponding average intensity along the coloured lines.
Reproduced from Nallala et al. [234].
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As the original definition in MIL-STD-150A itself is not publicly accessible, the thesis
relies on a secondary citation of it given by Earl F. Glyn [235] (see figure 5.3).
Figure 5.3: Definition of the original 1951 US air force standard resolving power test target
element. Reproduced from Glyn et al. [235]: From MIL-STD-150A: ”The patterns of lines are
parallel lines 2.5/x millimeters long and 0.5/x millimeters wide with space 0.5/x millimeters
wide between the parallel lines, where x equals the number of lines per millimeter.”
Since the distance between two elements(D(Ei, Ei+1)) in one group is not further
specified in the citation it was defined to D(Ei, Ei+1) = 4xi to have sufficient spacing.
In order to be able to study Mie scattering related effects using the target the USAF
pattern is extended by circular features. The target consists of elements (see figure
5.4) which are made up by features. An element consists of a 3 × 3 array of circles, a
set of 3 vertical lines and 3 horizontal lines. The size (x) of a feature (in mm) is given
by equation 5.1:
x = 0.52Group+1+(Element−1)/6 (5.1)
Figure 5.4: New resolving power test target element and relationship of feature sizes (x)
Six elements in different sizes make a group and two groups make a layer. A rectangle
of the size of the next smaller layer is added to each layer as well for calibration
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purposes. The target designed here covers the groups 4 to 9 with feature sizes ranging
from 32 µm to 0.55 µm , as displayed in table 5.1.
Table 5.1: Feature sizes for new resolution test chart.
Group Number
Element 4 5 6 7 8 9
1 31.25 15.63 7.81 3.91 1.95 0.98
2 27.84 13.92 6.96 3.48 1.74 0.87
3 24.80 12.40 6.20 3.10 1.55 0.78
4 22.10 11.05 5.52 2.76 1.38 0.69
5 19.69 9.84 4.92 2.46 1.23 0.62
6 17.54 8.77 4.38 2.19 1.10 0.55
Figure 5.5: New resolution test target.
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5.3 Manufacturing of New Target
The targets are manufactured by standard clean room procedures. First, approximately
1 ml of PMMA 950K A11 (Microchem; dissolved in Anisole), is pipetted onto a
1 cm×1 cm CaF2 chip (Crystan; 0.5 mm thickness) and spun in a spin coater at 4000
rotations per minute for 3 minutes. After spinning, the chip is placed on a hot plate
at 180 ◦C for 2 minutes. This procedure evaporates the solvent and cross links the
PMMA and results in a layer of approximately 2 µm thickness.
Afterwards, an additional aluminium layer of approximately 15 nm thickness is evapo-
rated onto the PMMA to provide conductivity for electron beam lithography. Then
the pattern is written by electron beam lithography. After lithography the aluminium
is removed with microposit MF-319 developer (Microchem). The written features
are then developed by bathing the substrate in a developer solution consisting of
15:5:1 Isopropylacohol:Methyl-isobutyl-ketone:Methyl-isopropyl-ketone for 60 s. The
developer dissolves the areas exposed to the electron beam and leaves the cross linked
areas intact.
The procedure can be adapted to also produce features made of gold in order to obtain
a high contrast, as gold is reflective in the MIR. To make gold targets, the negative
of the pattern needs to be written with electron beam lithography. Following the
development, gold can be evaporated onto the substrate. Afterwards, the substrate
is put into acetone which dissolves the cross linked PMMA and leaves behind the
features as metallic gold. As the last step the chip is mounted in a custom 3d-printed
holder of standard microscopy slide size (see figure 5.6).
Figure 5.6: Photograph of new resolution test target.
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5.4 Characterisation of New Targets
5.4.1 White-light Microscopy
The manufactured targets were characterised using a Zeiss Axio Scan Microscope.
The target manufactured with features made of deposited gold is displayed in figure
5.7. The manufacturing worked down to group 9 or 10 which is already outside of the
resolution of the white light microscope used for characterisation. Using the target,
the microscope‘s spatial resolution can be estimated to be between 690 and 780 nm,
as feature 3 of group 9 is still resolved but feature 4 is not.
Figure 5.7: Microscope image of manufactured resolution test chart made of 30 nm gold on
CaF2 with intensity profile.
Figure 5.8 shows a target made of PMMA on CaF2. Manufacturing the features in
PMMA proves to be difficult as the adhesion of the PMMA to the CaF2 is rather
poor for the small features.
Writing the pattern as a negative works better, as depicted in figure 5.9. The PMMA
does however show cracks.
5.4.2 FTIR Imaging
In order to investigate the usability the new targets have also been imaged on
an Agilent Cary FTIR system (Agilent 670 FTIR spectrometer coupled with an
Agilent 620 FTIR microscope). The system consists of a Globar source, and a liquid
nitrogen cooled 128×128 pixels focal plane array (FPA) mercury cadmium telluride
detector. A Cassegrain IR objective with numerical aperture (NA) of 0.62 and 15×
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Figure 5.8: Microscope image of manufactured resolution test chart 2.5 µm PMMA on
CaF2.
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Figure 5.9: Microscope image of manufactured resolution test chart with negative pattern
in 2.5 µm PMMA on CaF2.
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magnification was used for imaging, resulting in an effective pixel size of 5.5×5.5 µm
(1.1×1.1 µm with high magnification optics). The interferometer was configured to
provide 4 cm−1 spectral resolution.
Figure 5.10 shows the MIR transmission spectrum (A) from the target and the
corresponding hyperspectral image (B). First off all it is to note that the image itself
contains artefacts produced by the imaging system. The image consists of a grid
of 3× 4 acquisitions stitched together to form a big mosaic image. This process
unfortunately is done by Agilent software in an automated fashion with no possibility
to fine tune for the user. The individual tiles are not aligned correctly as evident in
the horizontal bars forming feature 2 of group 4. Feature 1 of group 5 is also not
aligned correctly as the tiles do overlap which is not accounted for. This results in the
image displaying 4 bars instead of 3. The border areas between tiles have to be seen
critically in the evaluation. Figure 5.10 C shows the absorbance values for the cross
section along feature 1 to 5 of group 5, highlighted in subfigure B in red for different
wavelength (colour coded in subfigure A, as well).
As discussed in section 5.1 already, these intensity profiles can be used to estimate the
spatial resolution of an imaging system. Here the effect of different spatial resolution
for different wavelengths in the hyperspectral image is evident. In the profile of the
2947 cm−1 image, all elements are clearly resolved (apart from element 5 which is
covered by a piece of dust), whereas for 1148 cm−1non of the elements are resolved any
more. Another interesting observation is the fact that the contrast does not appear
to be homogeneous across the field of view of each individual tile. This can be seen
in the stitching artefact present at feature 1 of group 5 where the two lower bars are
present in both tiles but show different absorbances.The spectral profiles (see figure
5.11) scanned across a feature 5 of group 4 do not show major spectral distortions.
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Figure 5.10: FT-IR spectrum of target composed of PMMA (A). MIR image of PMMA
positive feature resolution target (B). Absorbance cross section along red line in subfigure B
(C).
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Figure 5.11: (A) MIR image of PMMA positive feature resolution target and (B) spectral
profile of the finger print region across feature 5 of group 4 (red line in A)
5.5 Discussion
The design of a new resolution test chart was demonstrated here covering spatial
features from 31.25 µm to 550 nm in size. Much work in this regard remains to be done
until the new design can be used routinely. The stability of PMMA is an issue for
example which needs to be addressed. A promising alternative is the photoresist SU-8
which is chemically highly stable, but difficult to spin coat onto CaF2. Furthermore the
dot features can be used to investigate scattering phenomena often being a problem
while working with biological cells.
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6.1 Introduction
Evaluation of histological tissue sections is the standard procedure to diagnose cancers,
yet evaluating those is a time intensive and highly subjective process [10]. In order
to speed up the process and to make it less observer dependent, MIR imaging has
been proposed as a tool which, in combination with machine learning approaches, has
shown promising results in several proof of concept studies [8, 103, 104, 133, 171, 172,
174, 175, 178–181, 222, 234, 236]. Two recent reviews on this topic were presented
by Hermes et al. [1] and by Wrobel and Bhargava [237]. Yet the clinical translation
of this technology is still in its development phase. In order to achieve an observer
independent workflow, much work regarding standardisation of procedures remains to
be done [184]. This chapter evaluates the influence of sample preparation on MIR
hyperspectral data analysis and compares two DF-IR systmes to an FTIR.
There are two main procedures for obtaining histological sections of biopsy tissue for
clinical diagnostics. In order to preserve the biochemical information contained in
the specimen, the tissue biopsy can be snap frozen in liquid nitrogen and cut with a
cryomicrotom. This however often produces artefacts in the sections due to folding
and ripping of the sections. The other option, which is much more common, is to
apply chemical fixation with formalin and then embed the specimen in paraffin prior
to cutting with a microtom.
Formalin fixed paraffin embedded (FFPE) sectioning tends to produce less cutting
artefacts and the remaining tissue block can be archived in a tissue bank, but the
fixation procedure removes all of the volatile components of the sample such as free
lipids. Most clinical workflows use FFPE sections as they are much more stable
and therefore more convenient to work with. Therefore, this study focuses on the
evaluation of FFPE samples.
The use of FFPE samples has been demonstrated with Fourier Transform microspec-
trometers (FTIR) utilising incoherent light sources such as a globar. The influence of
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the paraffin for this setting has been evaluated by Nallala et al. [113]; they also propose
a chemometric workflow to eliminate spectral contributions of the paraffin referring
to it as ‘electronic deparaffination‘. This work builds on the study of Nallala et al.
by considering the effect of coherent light sources as well. Furthermore, the effect of
electronic deparaffination on the downstream machine learning procedure to classify
pathology groups from FFPE tissue sections is evaluated.
6.2 Material and Methods
6.2.1 Tissue Samples
The sample investigated is a tissue micro array containing two samples each, from 35
patients with oesophageal adenocarcinoma and 5 healthy controls. Three consecutive
sections (7 µm tick) have been purchased from US Biomax. The first section has
been mounted on a calcium fluoride slide (Crystan) for investigation with an FTIR
system, the second one on a MirrIR slide for investigation with QCL discrete frequency
imaging, and the third one on a standard histological glass slide to provide gold
standard reference information from a histopathologist via H&E staining as depicted
in Figure 6.1.
6.2.2 Data Acquisition
FTIR images were obtained using an Agilent Cary FTIR system (Agilent 670 FTIR
spectrometer coupled with an Agilent 620 FTIR microscope). The system consists
of a globar source, and a liquid nitrogen cooled 128×128 pixels focal plane array
(FPA) mercury cadmium telluride (MCT) detector. A Cassegrain IR objective with
numerical aperture (NA) of 0.62 and 15× magnification was used for imaging, resulting
in an effective pixel size of 5.5×5.5 µm. The interferometer was configured to provide
4 cm−1spectral resolution.
QCL discrete frequency (DF) imaging was performed on an Agilent LaserDirect IR
imaging system with a transflection sampling geometry. The instrument scans a
diffraction limited laser spot over the sample and was configured to record absorptions
point by point with 3 µm step size via a 0.72 NA refractive objective and a room
temperature bolometer detector. The laser source was tuned to acquire images every
8 cm−1between 950 and 1800 cm−1.
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Figure 6.1: Tumour (left) and healthy (right) sample (top) annotations (bottom)
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A second set of DF images of wavelengths, that were specifically selected based on the
study by Old et al. [171] was measured using an in-house built QCL system. Namely
at the frequencies (in cm−1) of: 995, 1024, 1030, 1045, 1082, 1108, 1117, 1143, 1162,
1216, 1238, 1254, 1271, 1304, 1338, 1353, 1369, 1374, 1395, 1440, 1452, 1465, 1475,
1483, 1510, 1535, 1546, 1563, 1587, 1632, 1653, 1658, 1673, 1687, 1727, 1743, 1765,
1780.
The system consists of a multi chip QCL unit (LaserTune, Block engineering) covering
the mid-IR fingerprint region from 770 to 1940 cm−1, with wavelength dependent peak
output power between 10 and 100 mW. A 0.56 N.A. image formation lens provided
a diffraction limited laser spot on the sample, which was scanned across the image
area using a high-speed linear motor microscopy stage (Prior). The transflected
radiation was recorded using a liquid nitrogen cooled, single-element MCT detector.
The design process and configuration of the system is described in great detail by
Mittal and Yeh et al. [238].
For both imaging procedures, the samples were measured first when they were still
embedded in paraffin. Then the paraffin was removed by submerging the sample
in n-hexane overnight, afterwards the samples were measured again using the same
acquisition settings. A second subset version of the mask was created as well leaving
clearance between pathology borders and leaving out areas that are difficult to
classify.
The H&E stained section was imaged under a standard white light microscope (Zeiss
AxioScan) with 10× magnification in reflection mode. The images obtained were
printed out and handed over to an expert pathologist (Prof. Neil Shepherd) for
annotation.
6.2.3 Image Preprocessing
The annotations obtained from the pathologist were digitalised using the original
white light images. The images were loaded into the open source software GIMP and
a false-colour mask was drawn manually and exported as a separate file (png).
The MIR images obtained from both FTIR and DFIR systems were loaded in their
proprietary formats onto Matlab, then cropped and co-registered with the H&E
images and the pathology masks using Matlab‘s built-in image registration tools. This
procedure assigned pathology information to every pixel of the MIR image.
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6.2.4 Spectral Preprocessing
The coregistered data were loaded into R via the ‘hyperSpec‘ package. All images were
cropped to uniform spectral range of 1000 to 1800 cm−1. The images from the sections
still embedded in paraffin were then electronically deparaffinated using a modified
version of the algorithm proposed by Nallala et al. [113] written in-house. The images
after chemical deparaffination were baseline corrected using a linear baseline fit. After
baseline correction or paraffin removal, respectively, the hyperspectral images were
filtered excluding all areas that did not contain sample or had extremely low signal.
The specific workflow with exact parameters and algorithms can be found in Appendix
4.
6.2.5 Data Analysis
The pre-processed images were further analysed in R using supervised classification
tools provided by the packages ‘caret‘, ‘pls‘ and ‘MASS‘. The fully pre-processed
dataset was split into test and training data. A 7-fold cross-validation scheme was
set up selecting five patient samples each from the tumour patients and the healthy
controls at random repeating this procedure to obtain 5 different splits each (See
Appendix 5.1 for details). Figure 6.2 visualises the hierarchy, whilst the samples used
for each model can be found in Table 6.1
Table 6.1: Samples used in PLS-LDA training sets
Set Tumour Samples Healthy Samples
1 A2 B6 C10 E3 F8 H2 H8 H4 H8 H10
2 A4 B8 D1 E5 F9 H8 H5 H6 H9 H5
3 A6 B9 D4 E8 G1 H5 H6 H1 H9 H1
4 A8 C2 D5 E9 G3 H2 H7 H1 H9 H8
5 A9 C3 D7 F1 G5 H8 H6 H5 H7 H6
6 B1 C5 D10 F3 G7 H3 H7 H7 H9 H8
7 B3 C8 E1 F6 G9 H10 H9 H3 H5 H8
6.3 Results
It has been previously demonstrated by Old et al. [171] that mid-IR spectroscopy
can be utilised to classify pathology of oesophageal tissue. Here the performance of
discrete frequency systems in comparison with conventional FTIR imaging system is
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Figure 6.2: Hierarchy of the design of experiments
assessed based on sample processing. Therefore, the set of oesophageal tissue samples
has been measured on both systems prior and after chemical removal of paraffin.
6.3.1 Instrumental Comparison
As depicted in figure 6.3, the images (raw data) obtained on the DF imaging systems
(figure 6.3 A-D) compare well to those obtained on the conventional FTIR (figure
6.3 E-F). In the spectral dimension the number of channels measured with the DF
systems can be scaled to the available measurement time, resulting in the potential
for much faster acquisitions. Imaging the sample depicted in figure 1 took about 20
min on the FTIR system (1506 channels, 10k pixels), 1h 20min on the Agilent QCL
system (106 channels, 31k pixels) and 20 min on the Bhargava‘s group system (40
channels, 70k pixels). Despite the decreased spectral resolution in the DF spectra,
the general spectral quality for a region of interest (figure 6.3 G) is comparable. The
image signal-to-noise ratio (SNR) for each channel (figure 6.3 H) is of the same order
of magnitude, as well (see Appendix Section 3 for details on how SNR was calculated).
There is however a notable difference in absolute intensity between the QCL systems
and the FT-IR. One factor contributing to this is the fact that the QCL systems
working in transflection effectively have double the interaction path length explaining
a factor of two.
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Figure 6.3: A-F: MIR absorbance images at 1658 cm−1for FT-IR and QCL systems with
paraffin and dewaxed (7 µm sections). G: Mean spectra of boxed areas in A-F colour-coded.
H: Object signal-to-noise-ratios for images A-F.
CHAPTER 6. QCL IMAGING FOR OESOPHAGEAL HISTOPATHOLOGY 73
6.3. Results
6.3.2 Dewaxing and Electronic Deparaffination
To evaluate the influence of paraffin embedding on the performance of classification,
models have been compared for the dewaxed data as well as for the paraffin embedded.
There are currently two different strategies to deal with the contribution of paraffin.
The first approach is to cut off the frequencies at which paraffin absorbs from the
spectra and discard them during analysis.
The second, more sophisticated approach is to model the spectral contributions of
the paraffin through a linear model which is referred to in the literature as extended
multiplicative signal correction (EMSC) [113, 239] or as multiplicative curve resolution
(MCR) [240]. This work uses a new algorithm written in-house in R.
The algorithm models the spectral profile of the paraffin based on the areas surrounding
the tissue (where paraffin is the only component) and estimates contribution scores
in the tissue using a non-negatively constrained linear model [241]. Thus a weighted
paraffin contribution can be subtracted from each pixel spectrum. The algorithm is
described in great detail with the full R code in Appendix Section 4.
6.3.3 Predicting Pathology Groups
After curating the 3 datasets: dewaxed data, truncated data and EMSC corrected
data, the images from each data set were used to set up a PLS-LDA model calculating
an LDA discriminant function from the first 10 PLS components. The model is set up
to discriminate between 6 pathology groups, two malignant types namely ‘necrosis‘
and ‘tumour‘, and 4 benign types: ‘stroma‘, ‘muscle‘, ‘replicating epithelium‘ and
‘mature epithelium‘. The model training was performed in a cross validation scheme
splitting the tumour patients into 7 groups of 5 patients each and assigning 5 random
samples from the healthy patients (see Appendix section 5.1). For each of these splits,
two models were trained, one utilising the full annotation of the entire image and the
second one with further curation of sub-regions of interest where the assignment of
pathology has a higher certainty.
The resulting 126 models were then used to obtain predictions from the samples
not used in training. The overall performance has quite large variability between
samples as well as between models, as discussed in more detail in Appendix section
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Figure 6.4: Average model performance for PLS-LDA models for prediction of pathology
groups.
5.2. The mean accuracies for the systems, treatments and different annotation masks
are plotted in Figure 6.4.
Considering the individual accuracies, chemical dewaxing is clearly working better
than electronic approaches. The overall accuracies however are considerably low.
6.3.4 Discriminating between ‘Benign‘ and ‘Malignant‘ at the Pixel Level
In order to improve on the low accuracy, another layer was added to the classification
method. The primary relevant information for the pathologist is whether the tissue is
classified malignant or benign. If the pathology groups were aggregated into these
two types, the overall accuracy increased substantially as depicted in figure 6.5.
The accuracies for the healthy samples increased even more than the overall per-
formance, as depicted in figure 6.5. It is the tumour samples that showed worse
performance, with a few samples in particular being classified with very low accuracies.
This matches expectations, as oesophageal cancers are very diverse in appearance [242,
243] and the sample set was relatively small.
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Figure 6.5: Average model performance for PLS-LDA models for classification between
benign and malignant.
6.3.5 Whole Sample Threshold Voting
To further improve the classification, whole sample classification or threshold voting
has been deployed as demonstrated by Old et al. [171]. Every sample with more then
30% of the pixels classified as malignant was therefore regarded as a tumour sample .
This approach does result in 93 % accuracy (see Table 6.2 for classifier metrics and
Appendix section 6 for details).
6.4 Discussion
FFPE tissue sections were used to discriminate pathological features using MIR
hyperspectral imaging. Results clearly suggest that chemical dewaxing is the favourable
sample preparation method and yields in better results than EMSC or truncation.
Data from the FTIR imaging system outperform those from the two QCL systems in
terms of prediction accuracy. Data acquisition times for the data sets were similar
for all three systems (ca. 15min per tissue core). It is however important to note



















































































Percentage of pixels predicted as benign
Figure 6.6: Average model performance for PLS-LDA models for classification between
benign and malignant for all samples.
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that it was not the aim of this study to optimise the acquisition speed for each
system. The main focus during method development was on spectral quality. There
are however different studies that have previously demonstrated methods to optimise
the acquisition rates. Those require prior knowledge of the classification task. In
FTIR imaging, spectral and spatial denoising can be used to increase acquisition rates
while maintaining data quality [244]. The acquisition speed of DF imaging systems
scales directly with the number of frequencies required for sampling the spectrum,
therefore variable importance projections can be used to identify the most relevant
frequencies and tailor the method exactly to the resources available [165].
This work developed an extended version of EMSC paraffin correction improving on
the work of Nallala et al.[113] by estimating paraffin spectral contributions in a more
robust fashion from the sample directly, instead of relying on separately measured
library spectra.
The chemical removal of paraffin prior to MIR imaging has been debated in the scientific
community, with some controversy between scientists in favour of removal and others
opposing it. Especially with coherent DFIR systems, this question had not been
addressed yet. Piling et al. [12] hypothesised that measuring tissue sections on DFIR
systems without chemical deparaffination would prevent optical artefacts, assuming the
paraffin serves as a refractive index matching medium essentially decreasing scattering
contributions to spectra.
In this study, scattering artefacts could not be identified either in the data from the
FTIR nor in those from the QCL systems. The study by Piling et al. used a different
type of DFIR system, set up in transmission geometry rather than transflection
geometry used in the present study. It is however known for FTIR imaging that
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transflection geometry is more prone to spectral artefacts [245]. There are indications
that coherent DFIR systems suffer worse from those artefacts [100]. The origin of
these pertubations, however is still debated [102].
Piling et al. suggested that the presence of paraffin is beneficial in transmission
geometry, but do not provide evidence to support this claim. A different set of studies
by Gerwert et al. [236, 246] which utilised the same type of transmission DFIR system
as Piling et al. did use chemically dewaxing and did not report artefacts. This should
however be directly addressed in a further study comparing systems which do not
differ in sampling geometry as this is a confounding factor which can only be discussed
indicatively here.
Looking at these two approaches in context of this work, there are no advantages to
report for leaving paraffin on the samples. This study rather suggests that there are
even benefits to removing it chemically as indicated by the better classifier performances
for the dewaxed samples. As reported by Fullwood et al.[247] and Nalalla et al. [113],
across a variety of different chemical dewaxing methods, none of them was capable
to remove paraffin entirely from the sample. These studies furthermore report that
the remaining paraffin content correlated with the tissue types and their density.
Therefore, paraffin remainder could potentially be used as an indirect marker for tissue
density.
The classification models as such do not perform as well as it was expected. The
challenge is clearly the small sample set with an unbalanced number of healthy controls.
Having only 5 samples per group is clearly not enough to capture and account for the
high variance in biological materials. The samples size is too small to be able to infer
whether this approach would work in a clinical routine. As theoretically determined
by Beleites et al. [248], to reliably demonstrate whether these kinds of models work,
hundreds of samples per group would be required. This issue is further discussed in
the outlook (see section 8.2.1).
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Disclaimer: This chapter is an adaptation from a submitted paper manuscript entitled:
‘Video-rate, mid-IR hyperspectral upconversion imaging‘ [249]. The manuscript was
still under review to the date of submission. The setup of the imaging system was built
by the main author of the publication Saher Junaid and fellow co-author Chaitanya
Kumar. The author contributed the samples to the experiment and did the data
analysis.
7.1 Introduction
Mid-IR hyperspectral imaging (HSI) is of major interest in diverse fields from medical
diagnostics [11, 133, 223, 234, 250], to environmental monitoring [251–253], geology
for mineral identification [254], and within the food industry [255]. The widespread
applicability of the mid-IR wavelength range (e.g. 2 to 15 µm ) is intimately linked to
intrinsic properties of molecular absorption.
As MIR spectroscopy and imaging delivers highly specific information, applications
are in need of sensitive, faster detectors, and cameras operating at room temperature
to efficiently harness this potential [253]. FTIR spectroscopy is toady‘s preferred
technique for MIR imaging as discussed in chapter 2. A major limitation to those
systems is, that the cameras used for MIR detection are predominantly based on
MCT, InSb or microbolometers, which either require cryogenic cooling and are of high
cost or have poor noise characteristics [256].
Moreover, for HSI, large data storage and complex post-processing software is currently
needed to transform raw data into useful information [106]. Recent developments in
mid-IR hyperspectral microscopy including tunable QCL illumination combined with
either raster scanning [238] or microbolometer array detectors [236] have shown their
potential to outperform FTIR systems for special applications.
Non-linear frequency upconversion provides an alternative route to enabling fast,
room-temperature mid-IR spectroscopy and imaging, due to orders-of-magnitude
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higher sensitivity and speed compared to direct mid-IR detectors [74]. A significant
drawback in previous demonstrations of upconversion imaging has been the need for
extensive post-processing to obtain a large field of view (FoV), which in turn prevents
its use for fast 2-D data acquisition or real-time video-frame-rate imaging [74, 257,
258].
In this chapter, first attempts utilising upcoversion for MIR spectral histopathology
are presented. Initial feasibility experiments are discussed first. This experience
gained was afterwards used to build a high-speed upconversion mid-IR monochromatic
imaging system. A synchronously-pumped OPO served as MIR illumination source.
This was combined with an upconversion detection scheme utilising a lithium niobate
crystal as non-linear medium, transferring the MIR signals to the NIR wavelength
range for image acquisition with a standard CCD camera.
7.2 Preliminary Experiments with Upconversion
7.2.1 Globar and Upconversion
In a very first attempt to use upconversion detection for biomedical diagnostics we
tried imaging a tissue section mounted on CaF2 in collaboration with DTU Fotnik. An
upconversion module as described by Dam et al. [74] was used with globar illumination.
Figure 7.1 shows the image obtained.
The quality of the image was poor, as the spatial resolution was too low and there
was no way to recover the hyperspectral information therefore the experiment was not
further evaluated. Increasing the spatial resolution however was not possible as the
module did not have sufficient sensitivity to image at higher magnification with the
globar.
7.2.2 QCL and Upconversion
As the setup of the upconversion module in combination with globar illumination did
not provide satisfying results the globar was swapped for a 6 µm wavelength QCL and
the magnification optics were upgraded to provide higher magnification. Figure 7.2
shows the image obtained.
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Figure 7.1: Mid-IR image of tissue section measured with globar illumination on upconver-
sion module described by Dam et al. [74].
Figure 7.2: Mid-IR image of tissue section measured with QCL illumination on upconversion
module described by Dam et al. [74].
82 CHAPTER 7. UPCONVERSION MIR IMAGING
7.2. Preliminary Experiments with Upconversion
The image has better magnification but still very poor contrast therefore the setup
replaced by the experiment described in the following section 7.3.
7.2.3 Supercontinuum Source and Upconversion
A second experiment with the same sample was conducted utilising a supercontinuum
source and a different upconversion approach as described previously by Huot et
al. [259]. The setup (see figure 7.3) consisted of 1550 nm erbium fiber laser as the
pump source for both the supercontinuum generation as well as the upconversion. The
pulse was then separated into two arms with a 90 to 10 fibre coupler. The higher power
pulse was propagated through single-mode silica fibers and a passive thulium-doped
non-linear fibre to generate a supercontinuum emission of 1.8 to 2.6 µm with an average
power of approximately 200 mW. The supercontinuum was then transmitted through
the sample. After passing through the sample the beam was recombined, using convex
gold mirrors (pump beam passed through a hole in the middle of the mirror), with
the pump beam focused in a non-linear lithium niobate crystal for upconversion to
860 - 970 nm. The upconverted signal was then detected with a standard CCD.
Figure 7.3: Sketch of Optical Setup of MIR imaging system described in Huot et al. [259].
As the upconversion phase matching strongly depends on the angle of incidence of the
beam into the non-linear upconversion crystal, (as described in 2.3.3) illuminating the
sample with a broadband source results in an effect similar to placing a grating in the
illumination path in the image. The angles are different for each pixel resulting in the
different wavelength being upconverted in different parts of the image [258].
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This profile was measured by scanning a fibre optic probe mounted on a micrometer
stage across the upconversion profile in the image plane. Figure 7.4 shows an image
obtained on the setup with the wavelength profile overlaid onto the image. This
process lacks accuracy, however, as the only point of reference to co-register the scan
with the image was the hole in the gold mirror.
Figure 7.4: Mid-IR image of tissue section measured with supercontinuum illumination
on upconversion arrangement described by Huot et al. [259]. The image is overlaid with a
visualisation of an estimation for wavelength upconverted at the respective pixels.
7.3 OPO Upconversion Optical Setup
Disclaimer: This subsection is a description of the OPO upconversion setup built by
S. Junaid and C. S. Kumar, modified from [249]. The author was involved in the
preliminary experiments leading to building this instrument and assisted in defining
the required specifications.
As the preliminary experiments suffered from poor optical design, this was addressed
by building a new system in an integrated approach.
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The setup (see figure 7.5) for upconversion of monochromatic images uses the idler beam
from a ps OPO as the MIR illumination source. The OPO is synchronously pumped
at 1064 nm by a ps Yb-fiber laser operating at a repetition rate of approximately 80
MHz (Fianium, FP1060-20; approximately 20 ps pulse length; approximately 1 nm
bandwidth). The power of 15 W, was split 2:1. 10 W to pump the OPO, and 5 W
(attenuated to 1.5 W to avoid saturation of the CCD camera) serving as a pump field
for the upconversion process via sum-frequency-generation (SFG).
The synchronous upconversion pumping scheme inherently locks the mid-IR OPO
pulses and the pump laser pulses, minimising timing jitter to ps scale. This intrinsic
feature of synchronously-pumped ps OPOs allows operation of the upconversion setup
in passive fashion, using a fixed delay line to synchronise the MIR OPO pulse and the
pump pulse to coincide inside the non-linear crystal [260]. Therefore, synchronous
pumping is highly efficient, as the high peak power pulses interact in perfect temporal
synchronism, resulting in efficient upconversion.
A MgO-doped periodically-poled LiNbO3 (MgO:PPLN) crystal is used as the non-
linear medium in the OPO, generating the signal and the idler beam. The crystal
is operated at constant temperature. Depending on the desired wavelength, either
the signal or the idler beam is accessible for illumination. The signal wavelength
can be tuned in the range of 1.43 to 1.98 µm with a bandwidth of <2 nm. The idler
beam correspondingly covers the range of 2.3 to 4.1 µm with a bandwidth of 4 to 6 nm
depending on the specific IR wavelength. The illumination bandwidth defines the
spectral bandwidth of the monochromatic images shown later. Further details of the
OPO can be found in [261].
In this work, only the idler beam was used for illumination of the object. Its beam
diameter was scaled to approximately 10 mm, defining the FoV in the object plane.
Depending on the wavelength, an average power of 750-900 mW was available for
illumination of the sample.
After passing the sample, the beam was focused (and recombined with the delayed
remainder of the pump beam) into a lithium niobate non-linear crystal for upconversion
via birefringent phase-matching. The large transverse dimension of bulk the lithium
niobate crystal compared to a PPLN analogue, allows the use of a large pump beam
diameter, enabling high spatial resolution in the upconverted images as the pump
beam acts as a soft Gaussian aperture [76].
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Figure 7.5: Setup for upconversion-based imaging, reproduced from [249]. The idler beam
from a ps OPO was used as an illumination source. A synchronised ps 1064 nm laser
source functioned as a pump source for the OPO as well as for the upconversion. The
beams were spatially and temporally overlapped in the non-linear crystal (lithium niobate)
for efficient upconversion. The phase-matching condition was scanned by rotating the crystal
in synchronism with the camera integration time. Lenses, (f1 = 50 mm) and f2 (50 mm,
and 100 mm), were used at the front and back focal plane of the 4f setup. filters (short-pass
950 nm, long-pass 700 nm) were used to block the residual pump and stray light.
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The upconversion setup is implemented in a 4f configuration, the upconversion process
takes place in the Fourier plane relative to the object. A first lens (f1=50 mm) Fourier
transforms the two-dimensional mid-IR object field to the centre of the lithium niobate
crystal, where synchronous upconversion to the NIR takes place. The second lens
(f2 = 50 mm and 100 mm) Fourier transforms the upconverted NIR signal back to
form the image at the CCD camera chip, see again figure 7.5. A silicon CCD camera
(Andor Luca S) was used for the image acquisition. Residual pump and stray light
were blocked by filters (short-pass 950 nm, long-pass 700 nm).
To increase the field of view beyond the angular phase-matching acceptance of the
non-linear crystal, angular rotation of the crystal was utilised [262]. Rotation of the
lithium niobate crystal angle by about 1◦ is implemented by mounting the crystal on
a Galvano-scanner (GVS), using ‘tangential phase- matching‘, see figure 7.6. This
rotation increases the field of view by a factor of approximately 5 compared to a fixed
crystal angle.
Figure 7.6: Upconverted images of a USAF resolution target at 3.1 µm by varying the
crystal rotation angle (-4.7◦, -4.3◦, -4.0◦), (d-f) and corresponding simulated images at the
same angles, reproduced from [249].
The FoV, using this approach, is limited primarily by the lens optics. The concept is
not specific to this setup and can be applied universally for any upconversion imaging
system. Another important feature of the scanning technique is the elimination
of image post-processing for large FoV monochromatic image upconversion. By
integrating all the upconverted sub-images, while scanning the crystal angle in a
predefined range, a large FoV is obtained without the need for post-processing.
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The monochromatic mid-IR upconversion imaging acquisition scheme was realised
with 2.5 ms acquisition time per frame, thus effectively achieving video frame rate.
The demonstrated spatial resolution estimated from an USAF chart comes to 35 µm
within a 10-mm-diameter FoV in the object plane, see figure 7.7 and 9 µm with a
3 mm FoV.
Figure 7.7: (a) Upconverted image of a USAF resolution target at 3.1 µm rotating the
crystal by 1◦ using a GVS synchronised to the camera integration time of 2.5 ms. (b)
Magnified version of the smallest features of the resolution target i.e. square box in (a), f2
was changed from 50 mm to 100 mm focal length for magnification. (c) Intensity profile along
the white line in (b) and pink circle highlights the smallest features, reproduced from [249].
7.4 Methods
Disclaimer: The following sections are the authors own work contributed to the
manuscript [249].
7.4.1 Tissue Samples
The sample used for investigation was a tissue micro array containing two samples
each, of 35 patients with oesophageal adenocarcinoma and 5 healthy controls. Two
consecutive sections have been purchased from Biomax.us. The first section has been
mounted on a CaF2 slide (Crystan) for investigation in the Mid-IR. The second biopsy
was mounted on a standard histological glass slide to provide a gold standard pathology
classification from a histopathologist (Prof. Neil Shepherd) via H&E staining. Here
one healthy and one tumour sample were selected for investigation.
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7.4.2 FTIR-Data Acquisition
FTIR images were obtained using an Agilent Cary FTIR system (Agilent 620 FTIR
microscope coupled with an Agilent 670 FTIR spectrometer). The system consists
of a Globar radiation source, and a liquid-nitrogen cooled 128 by 128 pixel focal
plane mercury-cadmium-telluride detector. A Cassegrain IR objective with numerical
aperture (NA) of 0.62 and 15× magnification was used for imaging resulting in an
effective pixel size of 5.5× 5.5 µm . The interferometer was configured to measure
spectra with 4 cm−1 spectral resolution.
7.4.3 Image Preprocessing
The annotations obtained from the pathologist were digitalised using the original
white-light images. The images were loaded into the open source software GIMP and
a false-colour mask was drawn manually and exported as a .png file. The MIR images
obtained from the FTIR as well as from the OPO-upconversion system were loaded
from the proprietary formats using MATLAB.
7.4.4 Upconversion Image Acquisition
To produce hyperspectral data, 62 HSI upconversion images were acquired (2.5 ms
exposure time each) in the 2770 to 3345 cm−1range. Namely at the frequencies (in
cm−1) of: 3344.48 3326.68 3304.69 3258.39 3245.70 3224.77 3198.98 3175.61 3154.57
3145.64 3139.72 3128.91 3126.95 3107.52 3107.52 3096.93 3086.42 3073.14 3069.37
3057.17 3048.78 3042.29 3036.74 3026.63 3025.72 3022.97 3015.68 2999.40 2997.60
2993.12 2979.74 2971.77 2969.12 2962.96 2956.83 2949.85 2942.91 2938.58 2936.00
2924.83 2923.98 2916.30 2904.44 2902.76 2896.03 2886.00 2877.70 2872.74 2869.44
2867.79 2857.96 2856.33 2849.00 2846.57 2836.07 2821.67 2814.52 2798.77 2790.96
2789.40 2779.32 2769.32
The biopsy images were then loaded into R via the ‘hyperSpec‘ package [263]. For
comparison, an FTIR imaging system was included, with cropped in the spectral
dimension, to match the spectral range of the OPO-upconversion system. The
upconversion spectra were then smoothed using a Loes-function [263] and analysed
using R‘s generic k-means functionality.
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The mid-IR illumination beam diameter was scaled to match the size of the medical
biopsy samples, which are 2 mm in diameter. The beam was then transmitted through
the biopsy sample, followed by 5x magnification to match the upconversion system.
See figure 7.8(a). The sample shown in the setup, figure 7.8(a) was a 7 µm thick
section of a tissue micro array purchased from Biomax.us (sample ID: ES8011a), see
section 7.4. The acquisition of two hyperspectral images, with and without the biopsy
sample inserted, allowed for a pixel-by-pixel calculation of the transmittance of the
sample, in this case at 3.34 µm , see figure 7.8(b). The spatial resolution at the object
plane was approximately 9 µm .
The speckled pattern observed in figure 7.8(b) can be atributed to the temporal and
spatial coherence of the illumination source. The bandwidth of the mid-IR OPO pulse
was approximately 5 nm, exceeding the Free Spectral Range (FSR) of the 1 mm CaF2
substrate by 30 %, thus significantly reducing fringing from multiple reflections in the
substrate. To remove the speckle arising from the spatial coherence in the image 5(b),
a spinning, ground glass diffuser (Thorlabs DG10-1500) was inserted into the beam
path. In this configuration, the illumination source was first reflected from the diffuser
(figure 7.8(a)) and then scaled to match that of the biopsy. Figure 7.8(c) shows the
image acquired using diffused, effectively incoherent light. As can be observed the
coherent interference patterns were minimised, however the CCD camera integration
time was increased to 400 ms to compensate for the insertion of the diffuser.
This HSI set-up was used subsequently. Figure 7.9 (bottom row) shows two stained
biopsy images representing cancerous and healthy oesophageal tissue and the corre-
sponding annotations, respectively. Figure 7.9 (first row) compares 2 biopsy images
obtained with the FTIR and upconversion system respectively. Figure 7.9, (third row)
shows the result of the k-means clustering in the spatial domain. Both morphology as
well as the spectral classification of the images correlate well with the histopathology
(figure 7.9 bottom row).
The FTIR images appear to resemble the pathologist‘s classification slightly better.
These differences could be attributed to the better signal to noise ratio of the FTIR
spectra. Figure 7.9 (second row) shows the k-means centre spectra.
To further compare the two systems, the images for the tumour sample are compared
in the following way. In a real world application, the total intensity information is
highly unreliable as it depends on the thickness of the sample. Sample thickness
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Figure 7.8: (a) Magnification setup for the imaging of the tissue sample to resolve the
smaller features of the sample. The original size of the beam emitted from the OPO is 10 mm,
which is reduced to 2 mm, using a pair of lenses: f1 = 250 mm, f2 = 50 mm. (b) Image of
the tissue sample acquired using upconversion at 3.34 µm wavelength. (c) Image when using
incoherent illumination, reproduced from [249].
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Figure 7.9: (Top row) Images of the tissue sample acquired using FTIR and upconversion,
spectral analysis of the cancerous and healthy tissue sample, based on upconversion imaging
and FTIR. (Bottom row) Stained biopsies evaluated by a pathologist and colour-coded
according to pathologies annotated, reproduced from [249].
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however, has a high uncertainty for histological sections because it is sensitive to
environmental factors, such as humidity and the sectioning procedure. In this specific
case, the information can be utilised, as images of the exact same sample are compared,
hence figure 7.9 shows non-normalised centre spectra.
In a clinical routine application however, spectra need to be normalised to account
for variations in sample thickness (effecting the optical path length in Beer-Lambert
type models). Figure 7.10 shows the k-means centres for both systems with the
spectra normalised to the 3300 cm−1channel prior to calculating the k-means centres
(after clustering however). Normalising to the 3300 cm−1channel, effectively expresses
every spectrum relative to it’s amide vibration intensity. This expression allows
interpreting the relative chemical composition of each pixel in relation to other pixels
while discarding the total intensity information. Discarding this information however
sacrifices contrast between tumour and other pathologies in the images with the
OPO-upconversion setup.
As can be seen in figure 7.9 the regions labelled as tumour are the areas with the
lowest total signal. The loss of contrast can be attributed to the fact that the signal
difference between the lipid signal (2850 to 3000 cm−1) and the amide peak (starting
at 3100 cm−1 and being cut of at the high wavenumber end of the spectrum) reaches
the same magnitude as the noise and therefore degrading the contrast without the
information of total intensity. The separation between the other three pathology
classes follows the same pattern between the setups, showcasing that the system
delivers hyperspectral imaging capability.
7.6 Conclusion and Outlook
A mid-IR monochromatic imaging system based on upconversion with an enlarged
field of view, capable of operating at video frame-rate (40 Hz), without the need for
post-processing of the images was presented for the very first time. In the setup, a
2.5 ms exposure time still required an attenuated pump beam to avoid saturation,
showing that a potential frame rate of 1 kHz could be realised using a faster silicon
CCD camera.
The high efficiency was obtained using a passively synchronised pumping setup. We
obtained 64 kpixels in the upconverted images, applying an only 1◦ of crystal rotation
with respect to the tangential phase-matching angle. The FoV was increased by a
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Figure 7.10: k-means centres (see figure 7.9 2nd row col 1 and 2) for tumour samples.
FT-IR left and OPO-upconversion setup. Spectra were normalised to the intensity of the
3300 cm−1channel. Black: Tumour, red: Muscle, green: Stroma, yellow: Necrosis (blue
background spectra were discarded).
factor of 5 compared to a static design, corresponding to an increase of 25 times in the
number of pixels. This number can be further increased by applying a larger numerical
aperture at the input side, combined with a correspondingly larger crystal rotation
angle. Eventually, the angular interrogation of the non-linear crystal for upconversion
will be limited by image distortion, originating from refraction at the crystal surfaces.
The mid-IR upconversion system operates at room temperature, unlike other low noise
mid-IR cameras with single photon detection capability, and with extremely short
response time, here demonstrated with 20 ps pulses.
Longer wavelengths could be upconverted using different non-linear crystals such as
AgGaS2 (e.g. 5-12 µm). This first application of a MIR OPO-upconversion instrument
provided hyperspectral data from human tissue biopsy sections. It was demonstrated
that a set of images from 62 wavelengths can enable preliminary, unsupervised
clustering of tissue types, with a similar performance to FTIR imaging. Much work
regarding stability and reproducibility for upconversion setups remains to be done,
however, before this technology can compete with the performance of a state of the
art FT-IR imaging system.
94 CHAPTER 7. UPCONVERSION MIR IMAGING
8 Discussion & Summary
The experiments discussed in this thesis showcase that the field of infrared imaging
undergoes rapid change at the moment. In this chapter the findings are discussed
in a broader context. First off all, addressing the new technologies each on their
own and finally highlighting potential synergy effects which could result from their
combination. After discussing the imaging technology the author wants to address
how this technology might be integrated into clinical routines.
8.1 Discussion of Technological Aspects
8.1.1 Impact of New Source Technology on Conventional MIR Imaging
Before 2010 only globars and occasionally synchrotorons were utilised as light sources
for MIR imaging systems. Now the portfolio of spectroscopists has increased by QCLs,
supercontinuum sources and OPOs. The effects of these sources on hyperspectral
imaging are however not fully understood. Deploying these new sources in conventional
fashion (MCT or bolometer camera for detection) bares some challenges as discussed
before. All of these sources are laser based technologies. Lasers are spatially more
coherent and usually polarised in contrast to thermal sources.
This has the consequence that first of all commonly used reflective optics are less
favourable to build an imaging systems, as the coherence does not allow for Schwarzschild
optics such as Cassegrain objectives to be used. The central obscuration of a Cassegrain
is highly dependent on the coherence of the illumination beam as discussed in chapter
2 and figure 2.4.
Furthermore, coherent sources are prone to speckle in wide-field imaging systems.
This can be avoided by deploying a point imaging geometry, which on the other hand
constrains measurement speed, as it is inherently slower than wide-field imaging.
Another way to avoid speckle is to break the coherence of the laser with a diffuser
element as discussed in chapter 7. This however decreases the intensity of the source
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and limits acquisition speed as the camera needs to record a full rotation of the diffuser
disk.
It is also important to note the difference between tunable monochromatic sources
(QCL and OPO) and broadband sources (supercontinuum). In a point scanning
geometry, broadband sources are advantageous as they can be combined with a
diffraction element to provide spectral resolution measuring a full spectrum with
each acquisition. In a wide-field setup monochromatic sources can be utilised if the
relevant information can be extracted from a few specific frequencies instead of a full
MIR spectrum. If a full spectrum is required, a broadband source is potentially still
favourable.
8.1.2 Impact of New MIR Detection Technology on Imaging
Considering new upconversion type cameras as discussed in chapter 7 design constraints
for a MIR imaging systems change compared to a conventional setting as discussed
in subsection 8.1.1. First of all the non-linear crystal imposes further wavelength
constraints as it needs to be transmissive for both the MIR signal and the visible or
NIR pump laser. To this date no crystal exits which is transmissive throughout the
whole MIR, while having a high non-linear refractive index. This work utilised a bulk
lithium niobate crystal enabling upconversion of MIR photons between 2 and 4.5 µm.
Other bulk crystals, e.g. AgGaS2, extend beyond 4.5 µm, thus affirming the generic
nature of the proposed concept and enabling further extension of the upconversion
imaging into the 5 to 15 µm range.
Designing an imaging system then depends on the sources as the angle dependency of
the upconversion (see figure 2.2) process needs to be taken into account. Building a
wide-field imaging system, a monochromatic source would be favourable, as a system
could be built utilising ‘tangential phase-matching‘ as discussed in chapter 7 getting
the spectral resolution from the source. This scheme, however, can not easily be
used with a broadband source as the images would consist of several rings containing
different frequencies (see figure 7.4) and therefore can not be integrated into a single
camera frame without losing the spectral information.
An alternative to the approach described above, would be to deploy a broadband source
in point scanning geometry coupled to an upconversion spectrometer (as described by
Tidemand-Lichtenberg et al. [78] for example) which to the authors knowledge has not
been done to this date.
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Deploying a monochromatic source in combination with upconversion detection in
point scanning geometry as described by Tseng et al. [264] does not provide any added
value compared to a Peltier cooled single element MCT1. The upconversion detector
does have a much higher technical complexity and to this date does not beat the MCT
in noise equivalent power and also is not likely to be significantly cheaper either.
A different added benefit of upconversion detection however could be gained if a visible
or NIR camera could be put to dual use in a system providing VIS/NIR capability
together with MIR imaging. Furthermore, there is also the possibility to use the pump
laser to excite Raman signals, as well.
8.2 Discussion of Clinical Aspects
Putting the clinical findings into perspective the major finding of the thesis is the
conclusion, that when working with paraffin embedded samples, it is clearly favourable
to remove the paraffin, but not strictly necessary. This is a constant point of debate
in the community.
8.2.1 Statistical Aspects
A major concern regarding the results is the statistical validity as only very few
samples have been available to build classification models from. Furthermore, not all
clinically relevant features for addressing adenocarcinomas were present in the dataset.
The dataset consisted of samples harvested from oesophageal resections and did not
contain areas with Barrett‘s oesophagus or dysplasia. This limitation of the sample
set was attributed to the fact that access to the different imaging systems was limited
and therefore one sample was chosen to focus on comparing the technical aspects
based on the data obtained from that sample. It remains an open question whether
MIR imaging is a suitable tool to differentiate between all the possible clinical cases
occurring in oesophageal tissue. Addressing this question comprehensively however is a
project far beyond the resources available within a single PhD project if a comparison
between several techniques is aspired.
1The paper itself compares against a liquid nitrogen cooled MCT and argues that the added value
is in making the liquid nitrogen redundant, which is only valid for cameras and not to single
element detectors.
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The 40 samples investigated in this thesis are not representative for larger populations
and even though a resampling strategy to minimise bias in the classification models was
developed, there are factors which can not be represented by resampling. Therefore, it
is sensible to assume that the models obtained are over optimistic from an information
theory point of view. The problem lies in the fact that the data space has a very high
dimensionality compared to the number of samples available for training [265]. This
has partially been addressed by the fact that the actual learning has been performed on
the data subspace projected by the PLS. The PLS decreases the dimensions (different
frequencies measured) from hundreds to 10 which decreases the magnitude of the
problem but still the sample size is too small as a typical rules-of-thumb recommends
at least 5 samples per dimension [266].
In order to build a classifier to asses oesophageal samples based on the Vienna
classification [196] (see section 4.3.2 and table 4.1), a data set is needed containing at
least 100 statistically independent samples per group [248] for testing the classifier
alone. Assuming the same amount of samples is required to train a classifier, this
results in a minimum of 1000 samples (1600 if subgroups should be taken into account)
required to prove with statistical confidence whether MIR imaging is a tool suitable to
support pathologists in their decision making. Measuring such an amount of samples
is however not as straight forward as it seems as such an experiment is likely to reveal
technical challenges (discussed in section 8.2.2) which have been irrelevant for smaller
models.
8.2.2 Technical Aspects
As discussed in section 8.2.1, in order to prove that MIR hyperspectral imaging could
be useful for histopathological applications an experiment on a much larger scale
measuring thousands of samples needs to be conducted. Technology is not the major
limitation here, since such an experiment could be conducted on state of the art
FT-IR microscopes. FT-IRs are producing high quality images in terms of spectral
quality. The main limitations in data acquisition on FT-IRs are spatial resolution and
measurement speed. QCL systems can address these speed constraints and potentially
also deliver higher spatial resolution. FT-IRs in theory could also deliver higher
resolution then demonstrated in this thesis. All the work on tissue samples however
has been conducted with an effective pixel size configuration of 5.5 µm although an
effective pixel size of 0.66 µm is achievable as demonstrated in chapter 5 with the
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setup. The problem with that configuration however, is that the globar is too weak a
source to deliver acceptable SNR in the images in a practical time.
The question which spatial resolution is required to build a good classifier however,
still remains unanswered. A very small study by Lloyd et al. [267] found that there
seems to be an effect comparing performance between a setup with 1.1 µm pixel size
to 5.5 µm but the data set was too small to be significant. In this work there was no
clear difference found relating to spatial resolution between the QCL point scanning
images recorded compared to the FT-IR images (see figure 6.3).
A further challenge for a large scale experiment is the reproducibility of measurements
across individual systems and over time. This is a very well known problem with
Raman hyperspectral mapping systems [268]. So far, this has not been a major issue
for MIR imaging. Most experiments were conducted on FT-IR systems, which are
referenced against Helium-Neon laser. Typically tey are very stable, resulting in the
FT-IR systems calibrations being stable as well. Moving away from those, towards
QCL or upconversion detection, would introduce a various moving components into
the systems which are difficult to monitor whether they stay in alignment or drift and
cause various different artefacts as reported occuring in Raman systems [268].
Assuming MIR can be used to aid decision making in pathology, in order to be useful in
clinical routines, a MIR system must be integratable into current workflows. Therefore
it must be fully automated and has to be able to be operated by a technician without
expertise in complicated optical setups.
Ideally, those workflows would not utilise CaF2 or BaF2 substrates as they are
expensive and very fragile. Alternatives are either low-e slides for transflection
imaging, silicon substrate for QCL imaging or even standard glass histological slides
for high wavenumber imaging.
8.3 Summary
This work has demonstrated the use of a new transmission resolution test target to
characterise MIR imaging systems in chapter 5. The new chart enables transmission
imaging in contrast to the conventional chromium on glass charts.
Chapter 6 discussed paraffin influencing samples to be measured with MIR imagining
systems. Spectral contributions of paraffin are correctable using EMSC models like
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the one developed in this thesis. The EMSC approach developed here deploys an
correction estimating paraffin spectral contributions from the paraffin surrounding
the sample instead of relying on library spectra, making it less sensitive to variations
in the paraffin.
This correction however requires more data points per spectrum to be measured
compared to chemically dewaxed samples. This is not a problem with conventional
FT-IRs as they always acquire the full spectrum over the entire MIR wavelength
range. If discrete frequency set-ups are to be used in the future, they are required
to utilise fewer wavelengths, in order to gain a speed advantage over FTIRs. In this
case accounting for paraffin via an EMSC model requires measuring more frequencies
and therefore more measurement time making it less favourable compared to chemical
paraffin removal.
In chapter 7 the first ever experiment combining an MIR-OPO providing 3-5 µm
wavelength radiation, with an upconversion detection scheme was discussed. This
approach is particularly interesting for clinical routines as it would allow working with
standard glass clinical histology slides, which is not possible via fingerprint (6-12 µm)
MIR imaging. This work demonstrated that those set-ups are in principle suitable for
MIR imaging of biological materials. Yet much work needs to be done to improve the
technology, to make upconversion on a par with state of the art FT-IR systems.
8.4 Conclusion
In conclusion this thesis presented that there are numerous MIR techniques evolving
at the moment. All of these techniques have proven to have advantages over particular
other techniques but none of them seems to outperform the conventional techniques
in all aspects to this date.
This work demonstrated the advancement and evaluation of mathematical deparaffi-
nation in comparison to chemical dewaxing. The direct comparison of dewaxed and
electronically deparaffinated samples highlights that chemical dewaxing is favourable
if the experiment allows for it.
With regard to novel technologies the use of QCLs, supercontinuum sources and
upconversion detection have been explored in different proof of concept experiments.
From those it can be concluded that upconversion and supercontinuum are still not
mature enough to be used in a routine setting but show great potential to reach that
100 CHAPTER 8. DISCUSSION & SUMMARY
8.5. Outlook
point in the future. QCLs however are technologically more mature already and offer
a potential to improve data aquistion speeds drastically compared to conventional
FTIR systems.
8.5 Outlook
8.5.1 Providing Clinical Evidence
As discussed previously, the data set produced in this work is to small to be significant
from a clinical perspective. In order to evaluate the potential of MIR imaging for
clinical use, a study with over 1000 patients is needed. Such a study could potentially
be done on carefully selected archive tissues.
Despite being relatively slow in acquisition speed, FT-IRs would still be the systems
favoured for this approach as they tend to provide the best data quality in terms of
SNR and spectral coverage. Having a data set allowing statistically significant analysis
would furthermore enable to explore to which extend spectral coverage and SNR can
be traded for faster acquisition.
As discussed in section 3.5 there are several strategies which can be deployed to
estimate which frequencies need to be measured to achieve maximum discrimination
power while substantially decreasing overall spectral coverage.
8.5.2 Photothermal Imaging
Another technique with the potential to dramatically change the field of MIR mi-
crospectroscopic imaging is photothermal spectroscopy. This technique only starts to
emerge to the date this thesis is written, nevertheless the author sees great potential
in this being applied for clinical MIR imaging in the future.
The general idea of probing photothermal effects is well established in combination
with atomic force microscopy [16]. As conventional MIR transmission and transflection
imaging is inherently limited by the diffraction limit of the infrared beam to scan
the sample, these techniques are limited to micrometer resolution in the best case.
Photothermal imaging is a detection technique which circumvents the diffraction limit
of the MIR beam by not measuring its depletion, but instead probing the sample with
a visible beam at the same time to sense the transient photothermal effect induced by
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the absorption of MIR photons. Therefore, it is diffraction limited only by the visible
probing beam achieving sub-micron resolution [269]. This concept has now been
extended to also be applicable to wide-field imaging [270]. Photothermal microscopy
therefore also has great potential as a tool for clinical application having the significant
advantage that it can be applied to thick samples and is not dependent on CaF2
substrates and liquid nitrogen cooled detectors.
8.5.3 Authors Opinion
From the personal perspective of the author much work remains to be done to
demonstrate whether MIR is a good tool for histopathology. Having spent over five
years in that research sector the community of scientists appears quite homogeneous an
while titles of talks changed, the conclusions did not change much during those 5 years:
‘more samples are needed and closer involvement of clinicians‘. The key challenge
appears to be of less of scientific nature rather than ‘logistic‘. No research group
seems to acquire enough samples for truly meaningful experiments (1000 patients and
more).
It seems that clinicians apart from a very few exceptions, see vibrational (MIR and
Raman) imaging techniques as a toy of a group of people with the metaphorical
hammer looking for a nail. In order to change this perspective, it is necessary to
demonstrate significant added value of these techniques, compared to the standard
clinical workflows such as H&E staining.
It is the authors impression that large parts of the community see machine learning
and chemometrics as a magic which will solve their problems if they just acquire
enough data. In order to overcome this, closer collaboration with statisticians is
urgently required, to prevent people from doing experiments which from a statistical
perspective were bound to be meaningless from the start.
The author hopes that the formation of the International Society for Clinical Spec-
troscopy (CLIRSPEC) will direct the community towards achieving these goals ad-
dressing the authors concerns.
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1 Setup
This document has been generated using R and Rstudio in markdown. Grey blocks
depict Rcode to illustrate how calculations were performed. Please note that much
of the code could have been written more efficiently, however the author decided on
purpose to present it in a way that is optimised for readability.
The first block of code here shows the R-packages used.
Packages <- c("hyperSpec","FTIR","gtools","plyr", "dplyr",
"ggplot2","gridExtra", "matrixStats", "caret",
"knitr", "MASS", "pls")
lapply(Packages, library, character.only = TRUE)
Loading the images of the first sample, labelled A1 on the TMA: https://www.biomax.
us/tissue-arrays/Esophagus/ES8011a.
Obtained on the different instruments as described in Materials and Methods.
data = list()
data[["Agilent QCL Dewaxed"]] <-
readRDS("F:/Data/QCL_Paper_supporting_information/Agilent_QCL_dewaxed_rawdata.RDS")
data[["Agilent QCL paraffin embedded"]] <-
readRDS("F:/Data/QCL_Paper_supporting_information/Agilent_QCL_rawdata.RDS")
data[["Bhargava QCL Dewaxed"]] <-
readRDS("F:/Data/QCL_Paper_supporting_information/Bhargava_QCL_dewaxed_rawdata.RDS")









Define a function to plot the data in the ggplot2 framework.
PlotIMG <- function(Image, title) {
p <- qplotmap(Image) +
scale_fill_gradient(low = "black", high = "white")+
theme_classic() +
theme(legend.position = 'none',
plot.background = element_rect(fill = "transparent", colour = NA),






for (i in seq_along(data)) {
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3 Estimating Signal to Noise Ratios
Signal-to-noise ratio (SNR) is a common metric for image quality. There are various
ways to calculate the SNR. For imaging, noise generally is estimated as the standard
deviation of the background of the image. In this specific case, we have images of
oesophageal tissue (the object) that also contain empty areas surrounding the tissue
(the background).
In order to differentiate between object and background, we use k-means clustering
and estimate the background as the cluster whose centroid has the lowest intensity
at the channel closest to the Amide-I peak maximum (1650 cm-1). The procedure is
shown for the FTIR data in the following:
spc <- data[["FTIR Dewaxed"]]
k=8 #number of clusters to be computed





means = decomposition(spc, cluster$centers, wl(spc))
spc$kmeans = as.factor(cluster$cluster)
centroidPlot <- qplotspc(means,
mapping = aes( x = .wavelength,
y = spc,
colour = .rownames,








text = element_text (size = 14)) +
scale_x_continuous(breaks=seq(1000, 1800, by = 200))+
scale_y_continuous(breaks = seq(0, 0.6, by = 0.1))
clusterMap <- qplotmap(spc,
106 APPENDIX . SUPPORTING INFORMATION QCL IMAGING
3. Estimating Signal to Noise Ratios
mapping = aes_string(x = "x",
y = "y",
fill = "kmeans")) +
scale_fill_manual ("kmeans",
values = rainbow(k),
guide = guide_legend(title = "Cluster")
) +
theme_bw()+









top = textGrob(paste0("K-means to separate sample and background"),
gp=gpar(fontsize=20,font=3)),
bottom = textGrob(paste0("Cluster ", which.min(means[[,,1650]]),





































K−means to separate sample and background
Cluster 8 chosen to represent background
bg <- spc[spc$kmeans == which.min(means[[,,1650]])]
signal <- spc[!spc$kmeans == which.min(means[[,,1650]])]
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The signal-to-noise ratio for every channel can now be obtained by deciding the mean
value of the absorption intensity for each channel by the standard deviation of the
background for that channel.
estSNR = function(spc) {
k=8 #number of clusters to be computed




means = decomposition(spc, cluster$centers, wl(spc))
spc$kmeans = as.factor(cluster$cluster)
bg <- spc[spc$kmeans == which.min(means[[,,1650]])]
signal <- spc[!spc$kmeans == which.min(means[[,,1650]])]
bgSds <- mean(bg)
bgSds[[]] <- colSds(bg[[]])
SNR <- mean(signal) / bgSds
SNR
}
4 Paraffin Correction Algorithm
In order to correct for the spectral contributions of the paraffin, its spectral profile
is needed. In previous approaches, those profiles were obtained from data recorded
separately and assumed to be invariant from the paraffin in the object. As this
invariance cannot be demonstrated and is likely to play a role, in the approach used
here the paraffin profiles are obtained from the areas of the image that do not contain
the actual sample. This approach is especially practical for processing tissue microarray
data, as measuring those always involves measuring paraffin areas as well. It might
be less practical for processing data from entire histological sections as obtained in
hospital routines.
In order to separate paraffin from sample areas, k-means clustering is used in the
same fashion as described above for calculating the SNR.
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spc = data[["FTIR paraffin embedded"]]
k=8 #number of clusters to be computed





means = decomposition(spc, cluster$centers, wl(spc))
spc$kmeans = as.factor(cluster$cluster)
p1 <- qplotmap(spc,
mapping = aes_string(x = "x",
y = "y",
fill = "kmeans")) +
scale_fill_manual ("kmeans",
values = rainbow(k),
guide = guide_legend(title = "Cluster")
)+
theme_bw()+




text = element_text (size = 14))
p2 <- qplotspc(means,











text = element_text (size = 14)) +
scale_x_continuous(breaks=seq(1000, 1800, by = 200))+
scale_y_continuous(breaks = seq(0, 2, by = 0.25))
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top = textGrob(paste0("K-means Results"),
gp=gpar(fontsize=20,font=3)),
bottom = textGrob(paste0("Cluster ", which.min(means[[,,1650]]),
" chosen to represent paraffin",




































Cluster 2 chosen to represent paraffin areas as modeling reference
paraffin <- spc[spc$kmeans == which.min(means[[,,1650]])]
sample <- spc[!spc$kmeans == which.min(means[[,,1650]])]
The object containing the spectra representing the paraffin background are now fed
into a principal component analysis to identify the main variations.
pca_model <- prcomp(paraffin[[]], center = FALSE)
Those spectral variations can be assumed to be independent on the sample and
therefore will be treated as perturbations of the ‘interesting’ spectral components
originating from pathology. The versions of the EMSC used in the literature and
described before suggest using the first n loadings, where n is a parameter of choice
that is never adequately defined.
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Here the number of loadings to be used for modelling the spectral variation is chosen
based on two criteria. First the total variance covered by each principal component
(PC) is assessed (see figure below). In this case the most of the variance is covered
in PC1, especially given that the PCA was performed on non-mean centred data.
Investigating the variance alone however does not help in estimating the number of
relevant PCs. It is possible to argue for anything between 10 and 15 PCs depending
on the sample complexity.
qplot(x = 1:20, y = (pca_model$sdevˆ2 / sum(pca_model$sdevˆ2))[1:20]) +














In addition to the variance explained, the structure of the PCs, also referred to as
loadings, can be utilized to judge their importance. In the figure below, the first 20
loadings are depicted.
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xlab( expression(Wavenumbers / cmˆ-1)) +
ylab(expression(Intensity/a.u.))
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The first two loadings can be interpreted as the paraffin IR spectrum, loading 3 to 9
show baseline effects (3-6) and paraffin peak position shifts (7-9). Loading 10 is clearly
recognisable as a water vapour spectrum. The loadings above number 10 however are
more difficult to interpret, whilst they explain less and less variance in the data, and
therefore they are not considered any further.
If the loadings would be used for spectral decompositions as depicted above, there
would be the issue that spectra could become negative, as the PCA does not favour
axis directions. If the loadings shall be used in a non-negative decomposition, this
issue needs to be addressed. In order to do so, the loadings can simply be inverted
if they represent the inverse of a spectrum as observable in PC 1 and 2. Therefore,
each loading is checked in that it is established whether its absolute maximum is a
positive or negative value. In case of a negative value, the loading can be inverted
by multiplying the loading vector by a factor -1. The author tried to circumvent this
problem by using a non-negative matrix factorisation (NMF) instead of the PCA, but
unfortunately its R implementation of the NMF package cannot handle the volume of
data in this project in a practical fashion (computation times of more than 17h for a
single image).
flip_loadings <- function(object){
flip_operator <- (abs(rowMins(object[[]])) < abs(rowMaxs(object[[]])))*2 -1




In summary, the first 10 loadings of the PCA were selected and inverted in case of
negativity. In order to use these to correct the paraffin contributions in the sample
spectra, these loadings can be subtracted. This subtraction however needs to be
performed in a weighted fashion as it is unknown how strong these contributions are
in each individual spectrum. The weights can be estimated via a linear decomposition
or in this case a non-negative linear least squares decomposition, as an ordinary least
squares decomposition would allow for negative spectra.
As a least squares fit however fits the entire spectrum, in order for this to work
reliably, a reference spectrum is needed as well. A spectrum obtained from fresh
frozen cut oesophageal tissue is used in this case and visualised in the figure below.
It is important to note here that this reference spectrum needs to be the same for
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all samples in a study as otherwise the reference spectrum used could introduce an
artificial bias to classification models.
load (file =paste0("D:/OneDrive - University of Exeter",
"/PhD/2017_01_26_Oesophagus_TMAs/tmp/tissue.Rdata"))
#spline spectrum to same wavenumbers as sample.

















The components for correction are then normalised as visualised below. Furthermore,
we introduce two more components for fitting a 0th and 1st order baseline via a
Vandermonde matrix.
#renaming hacks to make the plot work correctly
loadings$PC <- as.character(loadings$PC)
tissue$PC <- "Tissue Reference"
#normalise everyting to 0 to 1 range
estimates <- normalize01(flip_loadings(loadings[1:10]))
#baseline fitting
ref <- vanderMonde (estimates,
1,
normalize.wl = normalize01)
ref$PC <- c("0th order Baseline", "1st order Baseline")
ref <- hyperSpec::collapse(tissue, ref, estimates)
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ref$PC <- factor(ref$PC, ref$PC)
qplotspc(ref,





facet_wrap ( ˜ PC , ncol = 2, labeller = labeller())+
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The components are then used to compute the non-negative least squares decomposition
(NNLS) of the data using fcnnls from the NMF package. This seems to be the fastest
implementation for the non-negative least squares method in R.
#actual EMSC part1
scores <- fcnnls(t(ref[[]]), t(spc[[]]))
#the NMF package works on column representations
#whereas hyperSpec works on collums, thus the mutliple use of t()
scores <- t(scores$x)
The scores obtained this way are an estimate for the magnitude of each of the
perturbations modelled by the EMSC. The total of these perturbations is subtracted
as the sum of each loading multiplied by its score obtained from the NNLS, only
keeping the modelled reference and the residuals (which contain the actually relevant
information).
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#actual EMSC part 2
spc[[]] <- spc[[]] - scores[,2:13, drop = FALSE] %*% ref[[2:13,, drop = FALSE]]
After correction of the paraffin contributions, k-means clustering can again be used to
identify and then discard all areas that can be considered as ‘voids’, as they should
ideally not contain anything else apart from paraffin (whose spectral contributions
were already eliminated).
k=5 #number of clusters to be computed





means = decomposition(spc, cluster$centers, wl(spc))
spc$kmeans = as.factor(cluster$cluster)
p1 <- qplotmap(spc, mapping = aes_string(x = "x",
y = "y",
fill = "kmeans")) +
scale_fill_manual ("kmeans",
values = rainbow(k),
guide = guide_legend(title = "Cluster")
) +
theme_bw()+




text = element_text (size = 14))








theme(plot.background = element_rect(fill = "transparent"
,colour = NA),
legend.position = 'none',
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legend.background = element_blank(),
text = element_text (size = 14)) +
scale_x_continuous(breaks=seq(1000, 1800, by = 200))+




top = textGrob(paste0("K-means Results"),
gp=gpar(fontsize=20,font=3)),
bottom = textGrob(paste0("Cluster ", which.min(means[[,,1650]]),
" chosen to represent empty",
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Cluster 2 chosen to represent empty areas to be deleted
As depicted above, the ‘void’ areas can now be removed and only the spectra containing
the actual sample are used for classifications of histopathological features.
5 Classification Routines
5.1 Validation Datasets
In order to validate the trained models, a scheme to mix cross validation and bootstrap-
ping was developed. The dataset is highly imbalanced with only 5 healthy patients
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versus 35 tumour patients. In order to build balanced models, the dataset is split
into 7 sets of 5 tumour patients. For each patient, a random sample is drawn. These
samples are then matched with 5 samples drawn with replacement from the 10 samples
of the 5 healthy patients.
set.idx <- list()
for (i in 1:7) {
#selecting samples form tumour patients
idx <- seq(1, 70, by= 14)+(2*i-1) - sample(0:1,5, replace = TRUE)
#adding 5 samples from healthy biopsies
set.idx[[i]] <- c(idx, sample(71:80, 5, replace = TRUE))
}










for (i in 1:80) {





dimnames = list(c("Set 1", "Set 2", "Set 3", "Set 4",
"Set 5", "Set 6", "Set 7"),
c("Tumour 1", "Tumour 2", "Tumour 3",
"Tumour 4", "Tumour 5", "Healthy 1",




for (i in 1:7) {
for (k in 1:10) {






caption = "Validation Training Sets",
align = "c")
Table 1: Validation Training Sets
Tumour 1 Tumour 2 Tumour 3 Tumour 4 Tumour 5 Healthy 1 Healthy 2 Healthy 3 Healthy 4 Healthy 5
Set 1 A02 B06 C10 E03 F08 H02 H08 H04 H08 H10
Set 2 A04 B08 D01 E05 F09 H08 H05 H06 H09 H05
Set 3 A06 B09 D04 E08 G01 H05 H06 H01 H09 H01
Set 4 A08 C02 D05 E09 G03 H02 H07 H01 H09 H08
Set 5 A09 C03 D07 F01 G05 H08 H06 H05 H07 H06
Set 6 B01 C05 D10 F03 G07 H03 H07 H07 H09 H08
Set 7 B03 C08 E01 F06 G09 H10 H09 H03 H05 H08
5.2 Classification Model Training
PLS-LDA was chosen as classification algorithm as it seems to have delivered the
most reliable results in the past. Random forest models were also tested and resulted
in similar classification accuracies. The author decided not to compare those results
here as the differences are very small and the key problems are seen elsewhere.
The code chunk below is the actual training of the classification models. Execution










for (i.dataset in 1:9) {
files <- list.files(datasets[i.dataset],








for (i.file in seq_along(set.files)) {
file = set.files[i.file]






spc <- spc[spc$annotation != "Not Annotated"]
spc$annotation = as.factor(spc$annotation)
localSave = paste0(datasets[i.dataset],"Full_Image_Model_", i.cv)
dir.create(localSave)
n.coef = 10







localSave = paste0(datasets[i.dataset],"subset_Image_Model_", i.cv)
dir.create(localSave)
spc <- tmp
spc <- spc[spc$annotation2 != "Not Annotated"]
spc$annotation2 = as.factor(spc$annotation2)
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n.coef = 10









5.3 Classification Model Predictions
The 126 models trained were then used to predict the pathology for all the samples
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recursive = FALSE)
for (i.core in seq_along(core.files)){
file = core.files[i.core]
test <- readRDS(file)
for (i.cv in 1:14) {
idx = set.idx[[rep(1:7,times = 2)[i.cv]]]
if (i.core %in% idx) next
savename <- sub(pattern = "PLS_LDA_model.RDS",
replacement= sub(".RDS", "", basename(file)),
model.files[i.cv])
plslda.model <- models[[i.cv]]




plslda.prediction <- predict (plslda.model$lda, newdata = PLSscores)
if(i.cv > 8){mask = "annotation"} else{mask = "annotation2"}
reference <- test[[,mask,]][test[[,mask,]] != "Not Annotated"]






5.4 Interpretation of Overall Performance
Plotted below is the accuracy of predictions for both training masks individually.
data = readRDS("F:/Data/2018_09_24_Prediction_AK.RDS")
p1 = ggplot(data[data$CV.mode == "full",], aes(x= Core, y= Accuracy)) +
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geom_point(aes(color = CV.set)) +
theme(axis.text.x=element_text(angle=90,size=6, vjust=0.5))+
facet_wrap(System ˜ Treatment, ncol=1) +
ggtitle("Accuracy for Full Annotation")
p1















































































































































































































































Accuracy for Full Annotation
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p2 = ggplot(data[data$CV.mode == "subset",], aes(x= Core, y= Accuracy)) +
geom_point(aes(color = CV.set)) +
theme(axis.text.x=element_text(angle=90,size=6, vjust=0.5))+
facet_wrap(System ˜ Treatment, ncol=1) +
ggtitle("Accuracy for Subset Annotation")
p2















































































































































































































































Accuracy for Subset Annotation
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The overall performance has quite a high variability between samples as well as



































The FTIR clearly outperforms the other two systems and the full annotation set
outperforms the subset. Accuracies of 60 to 70% however are not good enough for
clinical diagnostics. For clinical diagnosis, this high level of annotation is not required
and therefore it can be traded to ignore misclassification within the groups of benign
and malignant and achieve higher accuracy.






BreakAnnotation <- function (x){





"Old Squamous" = "benign",





for (i in seq_along(files))
{
tmp = readRDS(files[i])
tmp[[1]] <- factor(tmp[[1]], levels = levels(tmp[[2]]))
tmp[[1]] <- BreakAnnotation(tmp[[1]])
tmp[[2]] <- BreakAnnotation(tmp[[2]])




p1 = ggplot(data[data$CV.mode == "full",],
aes(x= Core, y= Ensemble.Accuracy)) +




facet_wrap(System ˜ Treatment, ncol =1) +
ggtitle("Accuracy for full annotation")
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p1




















































































































































































































































Accuracy for full annotation
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p2 = ggplot(data[data$CV.mode == "subset",],
aes(x= Core, y= Ensemble.Accuracy)) +




facet_wrap(System ˜ Treatment, ncol = 1) +
ggtitle("Accuracy for subset annotation")
p2




















































































































































































































































Accuracy for subset annotation
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BreakAnnotation <- function (x){





"Old Squamous" = "benign",





for (i in seq_along(files))
{
tmp = readRDS(files[i])
tmp[[1]] <- factor(tmp[[1]], levels = levels(tmp[[2]]))
tmp[[1]] <- BreakAnnotation(tmp[[1]])
tmp[[2]] <- BreakAnnotation(tmp[[2]])




6 Whole Sample Classification: ‘Threshold Voting’
cancercount = list()
for (i in seq_along(files))
{
tmp = readRDS(files[i])
tmp[[1]] <- factor(tmp[[1]], levels = levels(tmp[[2]]))
tmp[[1]] <- BreakAnnotation(tmp[[1]])
tmp[[2]] <- BreakAnnotation(tmp[[2]])
cancercount[[i]] <- confusionMatrix(tmp[[1]], tmp[[2]])
cancercount[[i]]$n.ref <- table(factor(tmp[[1]],
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for (i in seq_along(cancercount)) {
tmp <- cancercount[[i]]
data[i,"predicted.benign"] <- tmp$n.pred[1] / sum(tmp$n.pred)
data[i,"reference.benign"] <- tmp$n.ref[1] / sum(tmp$n.ref)
}
p2 = ggplot(data[data$CV.mode == "full",],
aes(x= Core,
y= predicted.benign)) +
geom_point(aes(color = CV.set)) +
facet_wrap(System ˜ Treatment, ncol =1) +
ggtitle("Percentage of pixels predicted as benign")
p2
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Percentage of pixels predicted as benign
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healthy <- c("H01", "H02", "H03", "H04", "H05",
"H06", "H07", "H08", "H09", "H10")
data[data$Core %in% healthy,"pathology"] <- "Healthy"
data[!data$Core %in% healthy, "pathology"] <- "Cancer"
data$pathology <- as.factor(data$pathology)
data$voted.prediction <- "Cancer"
data[data$predicted.benign > 0.7,"voted.prediction"] <- "Healthy"
data$voted.prediction <- as.factor(data$voted.prediction)
fullAnno <- data[data$CV.mode == "full",]
confusionMatrix(fullAnno$voted.prediction,
fullAnno$pathology)
## Confusion Matrix and Statistics
##
## Reference
## Prediction Cancer Healthy
## Cancer 3838 59
## Healthy 257 301
##
## Accuracy : 0.9291
## 95% CI : (0.9211, 0.9364)
## No Information Rate : 0.9192
## P-Value [Acc > NIR] : 0.007554
##
## Kappa : 0.6183
## Mcnemar's Test P-Value : < 2.2e-16
##
## Sensitivity : 0.9372
## Specificity : 0.8361
## Pos Pred Value : 0.9849
## Neg Pred Value : 0.5394
## Prevalence : 0.9192
## Detection Rate : 0.8615
## Detection Prevalence : 0.8747
## Balanced Accuracy : 0.8867
##
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## 'Positive' Class : Cancer
##
7 R Configuration Used
sessionInfo()
## R version 3.4.3 (2017-11-30)
## Platform: x86_64-w64-mingw32/x64 (64-bit)
## Running under: Windows 10 x64 (build 17134)
##
## Matrix products: default
##
## locale:
## [1] LC_COLLATE=English_United Kingdom.1252
## [2] LC_CTYPE=English_United Kingdom.1252
## [3] LC_MONETARY=English_United Kingdom.1252
## [4] LC_NUMERIC=C
## [5] LC_TIME=English_United Kingdom.1252
##
## attached base packages:
## [1] grid stats graphics grDevices utils datasets methods
## [8] base
##
## other attached packages:
## [1] corpcor_1.6.9 pls_2.6-0
## [3] MASS_7.3-47 knitr_1.20
## [5] caret_6.0-78 matrixStats_0.54.0
## [7] gridExtra_2.3 dplyr_0.7.4
## [9] plyr_1.8.4 gtools_3.5.0
## [11] FTIR_1.05 NMF_0.20.6
## [13] cluster_2.0.6 rngtools_1.2.4
## [15] pkgmaker_0.27 registry_0.3
## [17] hyperSpec_0.99-20171005 ggplot2_3.0.0
## [19] lattice_0.20-35
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##
## loaded via a namespace (and not attached):
## [1] nlme_3.1-131 lubridate_1.7.2 dimRed_0.1.0
## [4] doParallel_1.0.10 RColorBrewer_1.1-2 rprojroot_1.2
## [7] tools_3.4.3 backports_1.1.2 R6_2.2.1
## [10] rpart_4.1-11 lazyeval_0.2.0 colorspace_1.3-2
## [13] nnet_7.3-12 withr_2.1.1 tidyselect_0.2.4
## [16] mnormt_1.5-5 compiler_3.4.3 labeling_0.3
## [19] scales_0.5.0 sfsmisc_1.1-2 DEoptimR_1.0-8
## [22] psych_1.7.8 robustbase_0.92-8 stringr_1.2.0
## [25] digest_0.6.12 foreign_0.8-69 rmarkdown_1.7
## [28] pkgconfig_2.0.1 htmltools_0.3.6 bibtex_0.4.2
## [31] highr_0.6 rlang_0.2.0 ddalpha_1.3.1.1
## [34] bindr_0.1 ModelMetrics_1.1.0 magrittr_1.5
## [37] Matrix_1.2-12 Rcpp_0.12.19 munsell_0.5.0
## [40] stringi_1.1.5 yaml_2.2.0 recipes_0.1.2
## [43] parallel_3.4.3 crayon_1.3.2 splines_3.4.3
## [46] reshape2_1.4.2 codetools_0.2-15 stats4_3.4.3
## [49] CVST_0.2-1 glue_1.2.0 evaluate_0.10
## [52] latticeExtra_0.6-28 foreach_1.4.4 testthat_1.0.2
## [55] gtable_0.2.0 purrr_0.2.4 tidyr_0.8.0
## [58] kernlab_0.9-25 assertthat_0.2.0 DRR_0.0.3
## [61] gridBase_0.4-7 gower_0.1.2 prodlim_1.6.1
## [64] xtable_1.8-2 broom_0.4.3 e1071_1.6-8
## [67] class_7.3-14 survival_2.41-3 timeDate_3043.102
## [70] RcppRoll_0.2.2 tibble_1.3.3 iterators_1.0.8
## [73] bindrcpp_0.2 lava_1.6 ipred_0.9-6
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(cit. on p. 6).
[37] K. Ohtani, M. Beck, J. Faist, “Double metal waveguide InGaAs/AlInAs quantum
cascade lasers emitting at 24 ?? m”, in Applied Physics Letters 09/2014, 105, 121115,
DOI 10.1063/1.4896542, (cit. on p. 6).
[38] O. Fedosenko, M. Chashnikova, S. MacHulik, J. Kischkat, M. Klinkmüller, A. Alek-
sandrova, G. Monastyrskyi, M. P. Semtsiv, W. T. Masselink, “Scaling the output
power of quantum-cascade lasers with a number of cascades”, in Journal of Crystal
Growth 05/2011, 323, 484–487, DOI 10.1016/j.jcrysgro.2010.11.131, (cit. on pp. 6,
8).
[39] W. T. Masselink, M. P. Semtsiv, Y. V. Flores, A. Aleksandrova, J. Kischkat in Proc.
SPIE 9989, (Eds.: D. H. Titterton, R. J. Grasso, M. A. Richardson), International
Society for Optics and Photonics, 10/2016, 99890B–1–9 (cit. on p. 6).
[40] N. Bandyopadhyay, M. Chen, S. Sengupta, S. Slivken, M. Razeghi, Ultra-broadband




[41] R. Centeno, D. Marchenko, J. Mandon, S. M. Cristescu, G. Wulterkens, F. J. Harren,
“High power, widely tunable, mode-hop free, continuous wave external cavity quan-
tum cascade laser for multi-species trace gas detection”, in Applied Physics Letters
12/2014, 105, 261907, DOI 10.1063/1.4905281, (cit. on pp. 6, 9).
[42] A. Hugi, R. Terazzi, Y. Bonetti, A. Wittmann, M. Fischer, M. Beck, J. Faist, E. Gini,
“External cavity quantum cascade laser tunable from 7.6 to 11.4 µm”, in Applied
Physics Letters 08/2009, 95, 061103, DOI 10.1063/1.3193539, (cit. on pp. 6, 9).
[43] W. Zhou, N. Bandyopadhyay, D. Wu, R. McClintock, M. Razeghi, “Monolithically,
widely tunable quantum cascade lasers based on a heterogeneous active region design”,
in 06/2016, 6, 25213, DOI 10.1038/srep25213http://10.0.4.14/srep25213, (cit. on
pp. 6, 8).
[44] Z.-W. Jia, L.-J. Wang, J.-C. Zhang, F.-Q. Liu, Y.-H. Zhou, D.-B. Wang, X.-F. Jia, N.
Zhuo, J.-Q. Liu, S.-Q. Zhai, Z.-G. Wang, “High Efficiency, Low Power-Consumption
DFB Quantum Cascade Lasers Without Lateral Regrowth”, in Nanoscale Research
Letters 2017, 12, 281, DOI 10.1186/s11671-017-2064-2, (cit. on p. 8).
[45] S. Slivken, S. Sengupta, M. Razeghi, “High power continuous operation of a widely
tunable quantum cascade laser with an integrated amplifier”, in Applied Physics
Letters 12/2015, 107, 251101, DOI 10.1063/1.4938005, (cit. on p. 8).
[46] A. Hugi, R. Maulini, J. Faist, External cavity quantum cascade laser, 08/2010
(cit. on p. 8).
[47] V. S. Starovoitov, J. F. Kischkat, M. P. Semtsiv, W. Ted Masselink, “Intracavity
photoacoustic sensing of water vapor with a continuously tunable external-cavity
quantum-cascade laser operating near 55µm”, in Optics Letters 11/2016, 41, 4955,
DOI 10.1364/OL.41.004955, (cit. on p. 9).
[48] G. Wysocki, R. Lewicki, R. F. Curl, F. K. Tittel, L. Diehl, F. Capasso, M. Troccoli,
G. Hofler, D. Bour, S. Corzine, R. Maulini, M. Giovannini, J. Faist, “Widely tunable
mode-hop free external cavity quantum cascade lasers for high resolution spectroscopy
and chemical sensing”, in Applied Physics B: Lasers and Optics 09/2008, 92, 305–
311, DOI 10.1007/s00340-008-3047-x, (cit. on p. 9).
[49] J. Kischkat, M. P. Semtsiv, M. Elagin, G. Monastyrskyi, Y. Flores, S. Kurlov, S.
Peters, W. T. Masselink, “Alignment-stabilized interference filter-tuned external-
cavity quantum cascade laser.”, in Optics letters 12/2014, 39, 6561–4, DOI 10.1364/
OL.39.006561, (cit. on p. 9).
[50] A. Lyakh, R. Barron-Jimenez, I. Dunayevskiy, R. Go, C. K. N. Patel, “External
cavity quantum cascade lasers with ultra rapid acousto-optic tuning”, in Applied
Physics Letters 04/2015, 106, 141101, DOI 10.1063/1.4917241, (cit. on p. 9).
Bibliography 145
Bibliography
[51] C. K. N. Patel, R. Barron-Jimenez, I. Dunayevskiy, G. Tsvid, A. Lyakh, “Two
wavelength operation of an acousto-optically tuned quantum cascade laser and direct
measurements of quantum cascade laser level lifetimes”, in Applied Physics Letters
01/2017, 110, 031104, DOI 10.1063/1.4974214, (cit. on p. 9).
[52] R. R. Alfano, S. L. Shapiro, “Emission in the region 4000 to 7000 via four-photon
coupling in glass”, in Physical Review Letters 03/1970, 24, 584–587, DOI 10.1103/
PhysRevLett.24.584, (cit. on p. 9).
[53] V. V. Alexander, O. P. Kulkarni, M. Kumar, C. Xia, M. N. Islam, F. L. Terry, M. J.
Welsh, K. Ke, M. J. Freeman, M. Neelakandan, A. Chan, “Modulation instability
initiated high power all-fiber supercontinuum lasers and their applications”, in Optical
Fiber Technology 09/2012, 18, 349–374, DOI 10.1016/j.yofte.2012.07.014, (cit. on
p. 9).
[54] J. Dudley, Supercontinuum generation in optical fibers, Cambridge University Press,
Berlin, 2010, p. 501 (cit. on p. 9).
[55] P. M. Moselund, L. Huot, C. D. Brooks, “All-fiber mid-IR supercontinuum: a powerful
new tool for IR-spectroscopy”, (Eds.: R. R. Alfano, S. G. Demos), in Proc. of SPIE
03/2016, 9703, 97030B–1–6, DOI 10.1117/12.2213129, (cit. on p. 9).
[56] C. R. Petersen, U. Møller, I. Kubat, B. Zhou, S. Dupont, J. Ramsay, T. Benson,
S. Sujecki, N. Abdel-Moneim, Z. Tang, D. Furniss, A. Seddon, O. Bang, “Mid-infrared
supercontinuum covering the 1.4-13.3 µm molecular fingerprint region using ultra-
high NA chalcogenide step-index fibre”, in Nature Photonics 09/2014, 8, 830–834,
DOI 10.1038/nphoton.2014.213, (cit. on p. 9).
[57] U. Møller, Y. Yu, I. Kubat, C. R. Petersen, X. Gai, L. Brilland, D. Méchin, C. Caillaud,
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[219] D. Townsend, M. Miljković, B. Bird, K. Lenau, O. Old, M. Almond, C. Kendall,
G. Lloyd, N. Shepherd, H. Barr, N. Stone, M. Diem, “Infrared micro-spectroscopy for
cyto-pathological classification of esophageal cells”, in Analyst 2015, 140, 2215–2223,
DOI 10.1039/c4an01884b, (cit. on p. 50).
160 Bibliography
Bibliography
[220] O. Old, G. Lloyd, M. Isabelle, L. M. Almond, C. Kendall, K. Baxter, N. Shepherd,
A. Shore, N. Stone, H. Barr, “Automated cytological detection of Barrett’s neoplasia
with infrared spectroscopy”, in Journal of Gastroenterology 2018, 53, 227–235, DOI
10.1007/s00535-017-1344-z, (cit. on p. 50).
[221] T. D. Wang, G. Triadafilopoulos, J. M. Crawford, L. R. Dixon, T. Bhandari, P. Sahbaie,
S. Friedland, R. Soetikno, C. H. Contag, “Detection of endogenous biomolecules
in Barrett’s esophagus by Fourier transform infrared spectroscopy.”, in Proceedings
of the National Academy of Sciences of the United States of America 2007, 104,
15864–15869, DOI 10.1073/pnas.0707567104, (cit. on p. 50).
[222] L. Quaroni, A. G. Casson, “Characterization of Barrett esophagus and esophageal
adenocarcinoma by Fourier-transform infrared microscopy”, in Analyst 2009, 134,
1240–1246, DOI 10.1039/b823071d, (cit. on pp. 51, 67).
[223] H. Amrania, G. Antonacci, C.-H. Chan, L. Drummond, W. R. Otto, N. a. Wright,
C. Phillips, “Digistain: a digital staining instrument for histopathology.”, in Optics
express 2012, 20, 7290–9, DOI 10.1364/OE.20.007290, (cit. on pp. 51, 80).
[224] M. J. Baker, H. J. Byrne, J. Chalmers, P. Gardner, R. Goodacre, A. Henderson,
S. G. Kazarian, F. L. Martin, J. Moger, N. Stone, J. Sulé-Suso, “Clinical applications
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